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ABSTRACT
A multifiber laser angiosurgery system was developed
which is capable of controlled laser ablation of arterial ob-
structions in vivo. Development of the system can be broken
down into a few important steps.
A laser light delivery scheme employing an optical fiber
enclosed in a transparent optical shield was developed to al-
low for the controlled delivery of laser energy.
Characterization of this delivery scheme using argon ion laser
light showed that quantitatively predictable tissue ablation
could be achieved. Ablation proceeded at a constant rate,
with the depth of the ablated crater increasing linearly with
time. The crater diameter approached the incident laser spot
diameter for sufficiently long exposure times. The ablation
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process was also shown to be additive if multiple exposures
were used, that is, each successive exposure produced an in-
crease in the crater depth equal to the exposure preceeding
it.
This delivery scheme was then extended to a multifiber
shielded laser angiosurgery catheter system, which was
designed to be capable of controlled laser ablation of
arterial obstructions. That system consisted of a multifiber
shielded catheter employing the controlled delivery scheme of
the transparent optical shield, an optical system which al-
lowed for remote location of the laser source and careful
shaping of the catheter's output beam profile, and a
sophisticated computer based control system to operate and
monitor the ablation process.
Characterization of that system demonstrated that, as be-
fore, ablation proceeds at a constant rate, with the depth of
the ablated composite hole increasing linearly with time, and,
as before, the ablation process was additive if multiple expo-
sures are used. An ablation yield, the volume of tissue
removed per unit of energy delivered, wag defined, and found
to be constant at a value of 0.16mm /J for many different
laser exposure parameter combinations. A threshold laser
power of 1W was identified, a minimum power required to over-
come the loss of energy through thermal diffusion. A thres-
hold exposure time of 10ms was also identified, corresponding
to a minimum energy that must be delivered to raise the
tissue's temperature to the ablation temperature and deposit
the latent heat of ablation. Histological evaluation of the
peripheral damage imposed by laser ablation showed that a
layer of 100-200um of vacuolization and hypereosinophilia sur-
rounded each composite hole, a level of damage that should be
acceptable.
The successful use of the laser angiosurgery system using
the multifiber shielded catheter was also demonstrated in an
animal model. Both controlled recanalization of the ob-
structed artery and evidence of proper healing of the treated
site were shown.
A simple theoretical model for laser ablation is also
presented which describes the way in which different laser and
tissue parameters effect the ablation process. The ablation
velocity and ablation efficiency predicted by this model were
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SECTION I
INTRODUCTION
1.1 ATHEROSCLEROTIC DISEASE
Arteriosclerosis is the name given to a group of diseases
generally characterized by a thickening of the arterial wall
and a loss of the wall's elasticity [1]. Of the three major
forms of arteriosclerosis, the most common is atherosclerosis
[1,2].
Atherosclerosis is a degenerative disease of the large-
and medium-sized arteries in which atheromas containing
cholesterol, lipoid and fibrous material, cellular debris, and
calcium are formed within the intima and inner media [1]. A
number of risk factors such as hypercholesterolemia, hyperten-
sion, smoking, diabetes, obesity, age, and lack of physical
activity have been correlated with the development of
atheromatous plaque, though a cause and effect relationship
has not been clearly established [1,3,4].
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Although the pathogenesis of atherosclerosis has been the
subject of intense investigation for many years, the exact
steps leading to the formation of atheromatous lesions is
still not clear. It is generally thought to be a complex com-
bination of two mechanisms: intimal injury and increased up-
take of lipid by the artery wall. Figure I.1 diagrams
schematically the steps that may be involved as these two
mechanisms proceed. High concentrations of low density
lipoproteins (LDL) induce endothelial injury and the adherence
and aggregation of platelets; platelet aggregation is
prompted further by the injury itself. The endothelial in-
jury, along with hyperlipoproteinemia, leads to an increased
rate of LDL penetration into the subendothelial space. Both
the increased concentration of LDL in the arterial wall and
factors released by the platelets are probably responsible for
the stimulation of smooth muscle cell proliferation and the
entrapment of LDL in the extracellular fibrous matrix which
secreted by them. The continual reiteration of this process
eventually gives rise to a space filling atheroma made up of a
fibrous region of proliferated smooth muscle cells, collagen,
and lipoid material and, eventually, a necrotic center of cel-
lular debris, cholesterol crystals and cholesterol esters, and
calcium deposits (see Figure 1.2 and Figure 1.3) [1,5-9].
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Figure I.1
Schematic diagram of the probable interac-
tions between the two major pathogenic
mechanisms of atherogenesis [6].
The process of atheroma formation begins early in life
with the appearance of fatty streaks in the intimal lining of
the arteries. The disease does not become clinically signifi-
cant however until at least 75% of the diameter of the
vessel's original lumen has been filled by the developing
plaque. At this point, blood
compromised.
flow becomes seriously
The disease most commonly manifests itself as
ischemic pain (i.e., angina or claudication) resulting from
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Figure 1.2
Major components of the advanced atheros-
clerotic plaque [1].
inadequate delivery of oxygen, aneurysm formation due to
deterioration of the artery, and stroke, heart attack, or in-
farct of some other tissue due to complete interruption of
blood flow (see Figure 1.4) [1,10].
Nearly one million Americans die each year as a direct
result of cardiovascular disease, making it the cause of al-
most half of all deaths in this country. Nearly five million
Americans are estimated to have significant coronary heart
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Figure I.3
Histological sections of advanced atheros-
clerotic plaques in the coronary arteries
of two people. Note the principal com-
ponents of fibrous cap and necrotic core
in each [1].
disease, with another two million suffering from strokes, both
largely due to atherosclerotic disease [2].
- 5 -
70-
60-
50-
O,
<40-
Z 30-
C,
< 20-
10-
The
[1] .
MYOCARDIAL
INFARCT
- -1
I l
%I I
natural
INTRODUCTION
ATHEROSCLEROTIC DISEASE
CEREBRAL GANGRENE OF ABDOMINAL AORTIC
INFARCT EXTREMITIES ANEURYSM
CLINICAL HORIZON 
CALCIFICATION
COMPLICATED LESION-
HEMORRHAGE, ULCERATION,
THROMBOSIS
FIBROUS PLAQUE
a) FATTY STREAK
0
Figure I.4
history of atherosclerosis
1.2 TREATMENT MODALITIES FOR ATHEROSCLEROTIC DISEASE
There are two major corrective treatments for occlusive
atherosclerotic lesions in popular use today: surgical bypass
and balloon angioplasty. Both of these modalities are
designed to restore full blood flow in the artery distal to
the obstructive lesion and return perfusion to the target tis-
sue. Although both modalities have enjoyed increasing success
over the last several years, each has some serious drawbacks.
- 6 -
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I.2.1 Arterial Bypass Surgery
The specifics of the bypass technique vary with the loca-
tion and size of the diseased artery. In most cases, a seg-
ment of vein or artery from elsewhere in the patient's body is
grafted to the diseased artery around the site of stenosis to
provide an alternate path for blood flow. Over 200,000
coronary bypass operations are performed annually in the
United States alone [2]. Success of this technique is very
good, with a national operative mortality rate of only 2.3%.
Bypass grafts usually provide adequate flow for seven to ten
years without complication or obstruction of the graft [1].
When the graft does fail, usually due to plaque formation in
the graft, the procedure can often be repeated once.
However, like any surgical technique, arterial bypass has
disadvantages. The surgery is very traumatic to the patient.
It is expensive; coronary artery bypass usually costs $16,000
or more, with a required hospital stay of seven to ten days.
Not all patients are good candidates for bypass surgery. If
atheromas are located diffusely throughout the vessel, a sig-
nificant increase in blood flow may not be realized. Some
vessels may be too small to make bypass feasible [1]. Because
most grafts occlude in several years and the procedure can
- 7 -
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normally only be repeated once, bypass surgery is usually
reserved for older patients.
1.2.2 Balloon Angioplasty
A more recently developed alternative is percutaneous
transluminal balloon angioplasty. In this technique, a
catheter with a small balloon at its distal end is inserted in
a peripheral artery and advanced to the point of occlusion.
The balloon is placed across the lesion where it is inflated
with several atmospheres of pressure. The artery wall and
plaque are fractured and displaced, leaving an enlarged lumen.
Because only a small incision is made in the skin, an-
gioplasty is much less traumatic to the patient, less expen-
sive, and requires only a few days of hospitalization. It can
also be repeated as many times as is required, making it the
procedure of choice for young patients not responding to medi-
cal management. The procedure is relatively safe, requiring
emergency bypass surgery in about 6% of patients, and with a
national mortality rate of less than 1% [1].
However, balloon angioplasty can not be performed in all
situations. It is usually used only for single vessel disease
(approximately 80% of cases). It cannot be used if the
remaining arterial lumen is too small to pass the catheter and
- 8 -
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deflated balloon. It can seldom be used near a point of bi-
furcation where it might crush the branching vessel. Long or
diffuse lesions can be treated with only limited success.
Perhaps the biggest drawback of balloon angioplasty however is
the recurrence of stenosis. From 15% to 20% of lesions
treated by balloon angioplasty reocclude to a point requiring
repeat treatment within six months, and nearly 60% reocclude
within two years [1].
1.3 LASER ANGIOPLASTY
Removal of atheromatous obstructions by ablation using
laser energy (so called laser angioplasty) has received a
great deal of interest from researchers as an alternative to
bypass surgery and balloon angioplasty. Conceptually, laser
ablation of atheromas has advantages over both of these
techniques. Since optical fibers can be used to carry laser
energy to the lesion, percutaneous techniques can be employed
making the trauma and cost imposed by surgery unnecessary. It
is hoped that removing the obstructive lesion by ablation,
rather than merely displacing it with a balloon, will produce
a good clinical result without the high restenosis rate which
plagues balloon angioplasty. Laser ablation may also be
-9-
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applicable as a treatment for long or diffuse lesions, and
lesions at arterial bifurcations.
Many researchers have demonstrated that many types of
tissue, including arterial tissue and atheromatous plaques,
can be ablated using laser light [11-13]. Further, Gerrity
studied the long term effects of laser ablation of atheroma-
tous tissue in a porcine model in which atherosclerotic le-
sions were produced by a combination of hypercholesterolemic
diet and balloon deendothelialization of the abdominal aorta.
Complete intimal healing with reendothelialization was found
within two weeks after laser ablation of lesions [14].
I.4 CURRENT APPROACHES TO LASER ANGIOPLASTY
Experimental use of lasers in the vascular system was
first reported in the early 1980's. Although research is be-
ing conducted at a large number of centers, laser delivery
systems designed for use in the vascular system have remained
relatively simple and unsophisticated.
I.4.1 Laser Systems
The wide variety of lasers being investigated for abla-
tion of atheromatous plaque can be broadly divided into two
- 10 -
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groups, continuous wave (CW) lasers and pulsed lasers, and
subdivided by wavelength.
Continuous lasers are characterized by the delivery of up
to hundreds or even thousands of watts of continuous power
over a broad range of the spectrum. The ablation mechanism of
these lasers is most likely to be thermal in nature, brought
on by the heating of absorbing material in the tissue and
vaporization of the tissue's water. The rapid generation of
steam carries away tissue components, which may be further
pyrolyzed by the incoming laser light. The three continuous
lasers attracting the most attention are neodimium:YAG
(Nd:YAG), carbon dioxide (CO2), and argon ion.
Nd:YAG lasers have proven their usefulness in photocoagu-
lation therapy such as the treatment of ulcers of the stomach,
esophagus, and colon, and have further been used in arterial
and nervous anastomosis [15]. However, the property that
makes this laser well suited for photocoagulation makes it
poorly suited for ablation. Nd:YAG radiation at 1.06um or
1.32um is weakly absorbed by most biological tissues [16].
Large zones of moderate tissue heating are easily obtainable,
but heating may not be intense enough for clean ablation.
Craters produced in arterial tissue with continuous Nd:YAG
- 11 -
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lasers are normally surrounded by large zones of thermal
necrosis [17].
The 10.6um radiation from CO 2 lasers is strongly absorbed
by tissue water and thus penetrates only a few microns into
the tissue [18]. This property has made the CO 2 laser a very
popular choice for surgical applications, where clean cuts and
rapid healing in many types of tissue, including atheros-
clerotic models in swine, have been demonstrated [14].
However, optical fibers which transmit 10.6um are not commer-
cially available, preventing the use of CO 2 radiation percu-
taneously.
Argon lasers fill a middle ground between Nd:YAG and CO 2.
The 488nm and 514nm radiation from the argon ion laser is ab-
sorbed in about 1/3mm of tissue [16], making it capable of
removing tissue without extensive thermal damage if the laser
intensity and exposure duration are carefully controlled. The
visible wavelengths of this laser are readily transmitted by
commercial optical fibers used in the communications industry.
However, argon ion laser radiation has proved ineffectual in
removing calcified plaque [19-21]. The use of the alternate
argon ion 356nm radiation may increase that laser's suitabil-
ity for tissue ablation because of the increased tissue
absorption of ultraviolet wavelengths.
- 12 -
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Pulsed lasers are characterized by the delivery of short
bursts of light with very high peak power, typically in the
range of megawatts for a fraction of a microsecond. The abla-
tion mechanism of these lasers is not well understood, but
postulated mechanisms range from thermal to photochemical pro-
cesses, with or without the formation of plasmas. A number of
pulsed laser systems, including excimer, pulsed Nd:YAG, pulsed
dye, and, to a lesser extent, pulsed CO 2 have been used to
create very clean craters in tissues of all types, including
calcified atherosclerotic plaque, kidney stones, and even bone
[19-21]. Recent studies have shown that erbium:YAG (Er:YAG)
and hydrogen fluoride (HF) lasers can produce similar results
[22,23]. However, the very high peak powers generated by all
of these lasers makes transmission through optical fibers dif-
ficult even at visible wavelengths.
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laser wavelength
type
tissue
absorber
excimer UV/pulsed
UV/pulsed
UV/pulsed
UV/pulsed
argon
193nm
248nm
308nm
351nm
VIS/CW 488-514nm
Nd:YAG VIS/pulsed
IR/pulsed
IR/CW
CO 2 IR/pulsed
IR/CW
532nm
1064nm
1.06um
10.4um
10.4um
protein
protein
no
difficult
protein difficult
protein difficult
* yes
* difficult
* difficult
*
water
water
yes
future
future
Nd: YAG
argon
pulsed dye
Er:YAG
HF
UV/pulsed
IR/CW
355nm
1.32um
UV/CW 351-364nm
pulsed
IR/pulsed
UV-IR
2.9um
IR/pulsed 2.6-3.lum
IR/CW 2.6-3.lum
Table I.1
protein
*
protein
difficult
yes
yes
* difficult
water
water
water
future
future
future
Lasers systems currently
for ablation of atheromas.
being explored
Wavelengths
range from well into the ultraviolet to
well in the infrared. Probable tissue ab-
sorbers and the availability of optical
fibers are noted.
* Tissue absorbs only weakly at these
wavelengths. The specific absorber in the
tissue is largely unknown.
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1.4.2 Laser Delivery Techniques
A number of schemes have been proposed to deliver laser
energy to a lesion in the vascular system. The common use of
optical fibers to carry the laser radiation in all of these
schemes has largely limited laser ablation systems to continu-
ous visible or near infrared laser radiation. The argon ion
laser has largely been the laser of choice.
The earliest delivery systems consisted of a single opti-
cal fiber passed through the lumen of a catheter. Others also
incorporated a coherent fiber bundle for visualization of the
arterial lesion during ablation.
The first successful attempt to recanalize occluded peri-
pheral arteries was performed in 1982 using a device of this
type [24]. An argon ion laser was used to treat a thrombus
produced in the ligated vessel of a dog. Histological ex-
amination showed that initial intimal necrosis was followed by
complete intimal healing after five days with no
post-treatment thrombus formation. Successful recanalization
of human atherosclerotic arteries, which were grafted into the
circulation of a dog, has also been demonstrated with a
similar device [25]. Nd:YAG lasers have been used to remove
model lesions produced in rabbits through the combined use of
a hypercholesterolemic diet and deendothelialization with
- 15 -
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limited success [26-28]. Unfortunately, results have been
plagued by complications due to aneurysm formation and/or
arterial perforation.
The first reports of clinical use of laser ablation of
atheroma was published in 1984, again using this simple
delivery scheme [29]. In five patients undergoing coronary
bypass surgery, an argon ion laser was used to recanalize
coronary stenoses of 80-90%. Recanalization was initially
successful in three of the five cases. Since that time, a
number of researchers have reported successful recanalization
of femoral arteries and popliteal arteries, using the argon
ion laser or the Nd:YAG laser delivered through simple fiber
optic systems [30-33]. However, control of the laser light
was a consistent problem, and balloon angioplasty was often
used after laser treatment, greatly clouding the results of
these studies.
In 1985, a different type of delivery scheme was intro-
duced in which the optical fiber was capped with a metal tip
which absorbed all of the laser radiation. The laser was sim-
ply used to deliver power to heat this, tip which in turn
heated the tissue to "melt" or "vaporize" the tissue it con-
tacted.
- 16 -
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This technique has been shown to reduce stenotic model
lesions induced in rabbits by the use of hypercholesterolemia
and deendothelialization [28]. Recently, the first reports of
clinical use of this device in a technique termed
"laser-assisted angioplasty" were published [34,35]. Eight
patients were treated to reduce stenosis of coronary arteries,
with one perforation and one acute thrombosis, along with two
cases of acute myocardial infarction. The use of
"laser-assisted angioplasty" has continued in the treatment of
peripheral arteries in a series of 56 patients [36]. Success-
ful treatment was demonstrated in femoral, popliteal, and
iliac arteries with only one perforation and two acute occlu-
sions due to thrombosis. However, all successful uses of the
metal tip delivery scheme have incorporated the use of balloon
angioplasty following treatment with the laser, making it al-
most impossible to interpret the results of these studies.
Some important modifications to both of these delivery
schemes have been proposed. In one, a sapphire ball is fixed
to the distal end of a single bare optical fiber carried in a
catheter. When used, the sapphire tip is brought into contact
with the tissue to be removed and the tissue is exposed to
laser light passing through the ball. In a second, a metal
tip is placed over the end of an optical fiber similar to the
- 17 -
INTRODUCTION
CURRENT APPROACHES TO LASER ANGIOPLASTY
one described above. However, in this case, a hole is placed
in the distal end of the metal tip which lets some fraction of
the laser light exit the tip and expose the tissue directly,
while the rest heats the tip itself. Results using both of
these schemes are largely pending, but the researchers have
demonstrated a desire to address the problem of controlled
delivery by defining to some extent the geometry of the tissue
wvich is irradiated.
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A
single lumen fiber
catheter
B
angloscope witn val ,>,.a
side port fiber
C
U
nntical metal
single lumen fiber tip
catheter
DU
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catheter fiber tip
E
nntirnl metal tin
single lumen fiber withfiber withcatheter end holeend hole
Figure I.5
Schematic diagram showing the five
delivery schemes most often used to
delivery laser energy to ablate atheroma.
A, a single bare optical fiber carried in
a simple catheter; B, a single bare opti-
cal fiber with a coherent bundle or angio-
scope for viewing; C, an optical fiber
with a laser heated metal cap; D, an opt-
ical fiber with a sapphire tip; E, a mod-
ified laser heated metal cap.
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1.5 LASER ANGIOSURGERY
Although previous studies have clearly demonstrated that
laser ablation of atheromatous plaque is possible, limited
success of safe, controlled removal of tissue has also clearly
demonstrated the need for a more quantitative understanding of
the tissue ablation process. A controlled laser light
delivery scheme and an integrated ablation system designed
specifically for tissue ablation are both essential if con-
trolled ablation is to be realized.
This has prompted the advent of what we term "laser an-
giosurgery", the precise removal of atherosclerotic arterial
obstructions by laser ablation under controlled conditions.
1.6 PURPOSE
The purpose of this study is to develop a successful
laser angiosurgery system, and demonstrate precise tissue ab-
lation using the concepts learned in its development. To that
end, the study can be divided into several sections. First, a
controlled means of laser light delivery will be explored
through the investigation of optically shielded single fiber
devices. Ablation using this light delivery scheme will be
characterized using argon ion laser light. Second, a simple
theoretical model will be presented which describes certain
- 20 -
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aspects of the ablation process. Although the full develop-
ment of this model is beyond the scope of this thesis, it can
be used as a tool to point out the importance of certain abla-
tion parameters and to predicting the effects of changing
those parameters. Third, a multifiber shielded angiosurgery
catheter will be described along with the ablation system
necessary to support its use. The ablation process using this
catheter and system will be characterized through the use of
ablation velocity and ablation yield measurements, and his-
tological evaluation of peripheral damage. Last, an example
animal experiment taken from a parallel collaboration at the
Cleveland Clinic Foundation will be described as a demonstra-
tion of the system's performance and workability in vivo.
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II.1 OVERVIEW
Three independent optical parameters which govern the
tissue ablation process are defined and a laser light delivery
scheme capable of controlling them, the optical shield, is
described. The optical shield delivery scheme will be em-
ployed in the design of the multifiber catheter ablation sys-
tem.
11.2 CONTROL OF OPTICAL PARAMETERS: THE OPTICAL SHIELD
During laser irradiation of any type of tissue, the rate
and extent of tissue removal is governed by three independent
optical parameters: the laser power incident on the tissue
(P), the exposure time (t), and the area of tissue irradiated
(A). A common design flaw in every laser delivery scheme
which directly exposes atheroma to laser energy has been the
lack of control of all three of these parameters.
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Figure II.1 illustrates the shortcomings of a bare fiber
delivery scheme. Laser light that is focused on the proximal
input end of an optical fiber emerges in a diverging, conical
beam dictated by the fiber's numerical aperture, or NA, which
is defined as: NA = sin(8) (see Figure II.1). The diameter
of the projected spot of light (d) and thus the diameter of
the irradiated circle of tissue, can be computed to be equal
to: d/2 = [1 2/(1-NA 2 )] 1 /2 , where 1 is the distance from the
distal output end of the optical fiber to the target tissue
surface. Unfortunately, experience has shown that even under
direct visualization using an angioscope, it is impossible to
control the distance 1, and thus impossible to control the
area of tissue irradiated.
The situation is further complicated by the lack of con-
trol over the medium through which the laser light must pass
after it leaves the optical fiber. Even if the artery is
flushed with saline, the inevitably imperfect purge will leave
blood remaining between the fiber's distal output end and the
tissue to be irradiated. Even a small amount of blood will
strongly absorb many wavelengths and scatter all wavelengths,
attenuating the laser light and making it impossible to con-
trol how much power actually reaches the tissue surface.
Release of ablation products and the formation of bubbles in
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Controlled:
1) time
D
I
S? ?
Figure II.1
Diagram illustrating the shortcomings of
the bare optical fiber delivery scheme.
The incident laser power and area of tis-
sue irradiated cannot be controlled.
the medium surrounding the tissue may further change the
amount of light that reaches the tissue.
The laser exposure time, which can be regulated by a
shutter in the laser beam proximal to the optical fiber, is
the only optical parameter that can be controlled. Hence,
controlled tissue removal cannot be achieved.
Figure II.2 illustrates how all of the optical parameters
can be controlled by enclosing the distal output end of the
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optical fiber in a transparent, protective optical shield.
When the output surface of the shield is positioned in contact
with the tissue to be irradiated and removed, it locally dis-
places any blood or other intervening fluid to provide a clear
field between the tip of the fiber and the target tissue. All
of the laser power emerging from the optical fiber reaches the
tissue surface (minus the known reflections at the inner and
outer surfaces of the shield). Since the optical fiber can be
rigidly fixed inside the shield, the distance between the
fiber's output tip and the tissue surface is fixed, fixing the
distance 1 and thus the spot diameter, and defining the area
of tissue to be irradiated. With the incorporation of a
shutter to control exposure time, all optical parameters are
controlled.
To a large extent, it would be possible to insure control
over all three laser parameters by bringing the output end of
an optical fiber into direct contact with the tissue itself.
In this way, the optical fiber plays the role of the optical
shield, displacing intervening fluid and defining a treatment
area equal in size to the fiber's core. However, it is un-
likely that the optical fiber could withstand the violent
reaction produced during ablation. In addition, the optical
shield allows for greatly increased flexibility in catheter
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Controlled:
1) time
2) power
3) spot size
Figure II.2
Diagram illustrating the control allowed
by incorporation of a transparent optical
shield. The incident laser power and area
of tissue irradiated can now be con-
trolled.
design by producing laser spot diameters which greatly exceed
the diameter of the optical fiber.
A number of other parameters can be derived from laser
power, exposure time, and spot diameter which, although not
independent, are useful in describing the laser/tissue
interaction and ablation parameters. They include the
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delivered laser energy (E) (the product of laser power and ex-
posure time, E = Pt), the incident laser intensity (I) (the
ratio of power to spot area, I = P/A), and the fluence (0)
(the product of laser power and exposure time divided by spot
area, 0 = Pt/A).
II.3 OTHER ADVANTAGES OF THE TRANSPARENT OPTICAL SHIELD
Along with providing the required control over all three
optical parameters, the optical shield concept provides some
other important advantages. During ablation, the reaction at
the distal output tip of the optical fiber is violent, leading
to char formation, corrosion, and tip damage [1,2]. The opti-
cal shield can protect the delicate optical fiber from this
potentially harmful environment. Fluid displacement should
reduce the unnecessary and undesirable heating of blood by
removing it from the light path. The blunt end provided by
the optical shield protects the artery from mechanical per-
foration by the sharp end of an optical fiber. The shield can
also be used to house additional optics, lenses, filters, mir-
rors, etc., if shaping of the laser beam is desired.
It is important to note that, although the optical fiber
is fixed within an enclosure, the optical shield differs
dramatically from the hot metal tip approach. Since the laser
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light passes through the optical shield and irradiates the
tissue directly, the tissue is heated by the absorbtion of
laser light, and not by a hot surface. The rate of energy
transfer to the tissue is thus dictated by the laser power
alone, and not by thermal conduction from the shield to the
tissue. Thus, it may be possible to deposit energy into an
atheroma much more rapidly by direct irradiation using an opt-
ical shield than by thermal conduction using a metal tip.
It is also important to note that the optical shield con-
cept is effectual only if the shield is brought into contact
with the tissue to be removed. All three optical parameters
are controlled only under those circumstances.
II.4 SELECTION OF A LASER SYSTEM
Conceptually, the optical shield delivery scheme can be
used with any laser system or laser wavelength for which opti-
cal fibers (or an equivalent light guide) and an optical
shield material are available. Current commercially available
optical fibers transmit well at all visible wavelengths and
into the near infrared. Fibers are also available which
transmit near ultraviolet with mixed success. Shield materi-
als such as glass or quartz are readily available for all of
these wavelengths as well. Unfortunately, the conduction of
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the very high peak powers generated by pulsed laser systems
and laser wavelengths further in the ultraviolet and infrared
by optical fibers pose problems that have attracted a great
deal of attention, but are yet largely unsolved.
For this study, the argon ion laser was selected to
demonstrate the ability to use the optical shield concept as a
controlled laser light delivery scheme and to develop a laser
angiosurgery system. The results should be applicable to
other laser systems as optical fiber technology improves.
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SINGLE FIBER SHIELDED DEVICE BEHAVIOR
III.1 OVERVIEW
A single fiber optically shielded device was constructed
to deliver argon ion laser light in a controlled way. It was
used to produce craters in atheroma to characterize the rate
of tissue ablation, and the size and shape of the craters pro-
duced. These experiments demonstrate that the use of the opt-
ical shield delivery scheme makes precise, quantifiable
ablation possible, and give some insight into how ablation
proceeds.
The purpose of this study was to demonstrate the worka-
bility of the optical shield concept and gain knowledge neces-
sary to develop an ablation system based on that concept. A
larger study designed specifically to investigate ablation
thresholds and evaluate the accuracy of the theoretical model
using similar single fiber shielded devices is being
- 35 -
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undertaken as a collaborative effort at the Cleveland Clinic
Foundation [1].
III.2 EXPERIMENTAL METHODS
The optical shield laser catheter constructed for these
studies consisted of an optical fiber with a carefully cleaved
or polished output tip rigidly centered inside a transparent
shield (Figure III.1). The fiber had a 133um core diameter
and a numerical aperture of 0.21. The shield was formed by a
length of 0.5mm thick quartz tubing of 3mm outer diameter,
closed at one end with a torch to form a hemispherical output
surface. The spot diameter (measured on the output surface of
the shield) was adjusted by choosing the appropriate distance
between the tip of the fiber and the output surface. Reticon
linear diode array measurements showed the beam profile to be
approximately uniform across the spot, falling rapidly to zero
at the edges (see Figure III.2). Spot diameter was measured
by immersing the device in a bath of water containing a small
amount of rhodamine laser dye to permit visualization of the
beam (see Figure III.3). The beam was observed perpendicular
to the axis of the device with a dissecting microscope, and
its diameter measured at the output surface of the shield with
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a reticle.
+ 25um.
Spot diameter determinations were accurate to
Figure III.1
Optically shielded single fiber device.
Tissue ablation studies were performed using blue-green
light (all lines) from a Coherent I-20 argon ion laser. Human
atherosclerotic carotid artery obtained at autopsy was cut
open lengthwise to expose the luminal surface. Samples, typi-
cally 1mm thick, exhibited relatively acellular intimal
fibroplasia, often infiltrated by lipid and foam cells,
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Figure 111.2
Single fiber shielded device output pro-
file measured with a Reticon linear diode
array.
overlaying media, and were selected for sample to sample uni-
formity. Each sample was placed in a petri dish and immersed
in either blood or saline solution. The tip of the optical
shield was brought into perpendicular contact with the luminal
surface, displacing the intervening fluid, and pressed against
it with a force of one ounce (0.28N). Laser power was meas-
ured at the output surface of the device to an accuracy of
+50mW using a thermal power meter. Exposure times, controlled
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Figure 111.3
Single fiber shielded device output as
visualized by immersing the device in a
bath containing laser dye.
by an electronic shutter placed in the laser beam, were ac-
curate to +2msec. Saline was used in most studies, since the
dimensions of craters produced in blood and saline were found
to be the same within experimental variability.
The craters formed by laser ablation were roughly
cylindrical with rounded bottoms. Crater diameter (d) was
measured at the luminal surface of the tissue using a
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dissecting microscope with an eyepiece reticle. Crater depth
(1) was measured using a histological microscope with a cali-
brated fine adjustment focusing knob, bringing first the tis-
sue surface and then crater bottom into focus. Measured
crater dimensions were accurate to +25um.
Craters were randomly selected for histological examina-
tion. Each was fixed in formalin, embedded in paraffin,
serially sectioned, and hematoxylin and eosin stained to
determine the degree of peripheral damage.
For each combination of ablation parameters of laser
power (P) and spot diameter, the ablation velocity (v), or the
rate of change of crater depth with exposure time (t), was
computed as the ratio: v = Al/At.
III.3 RESULTS
Three separate experiments were performed to characterize
the ablation process under varying ablation parameters and
conditions. In all cases, mean crater depths and diameters
were computed from at least six individual craters. The mean
values are reported, along with error bars indicating the en-
tire range of values, for each set of ablation parameters.
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III.3.1 Variation in Ablation Rate with Varying Power
The existence of a power dependence on the rate of tissue
ablation and crater formation was examined by producing
craters using single laser exposures through a shielded device
with a 750um spot diameter. Craters were made with several
different exposure times at 2.5W, 5.0W, 7.5W, and 10.0W.
The craters produced were relatively free of char at all
power levels and exposure times, with a slight increase in
char production at lower powers and longer times. Histology
showed a narrow layer of vacuolation and hypereosinophilia
surrounding the crater. A region beyond that showed slight
collagen alteration typified by an increase in unstained space
without hypereosinophilia. The structure of the arterial wall
did not appear to be compromised by this change. A typical
histological section is shown in Figure III.4. Occasional
splits in the media were observed radiating from the produced
crater in many cases. Qualitatively, the thickness of the
layers of vacuolation and collagen alteration decreased with
decreasing delivered energy, that is, with decreasing power at
the same exposure time and with decreasing exposure time at
the same power. Almost no vacuolation or collagen alteration
was observable for short exposure times at 10.0W power levels.
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Figure III.4
Typical histological section through a ab-
lated crater. Photon dose for this crater
was 5W/100ms, and a 750um spot diameter
was used. Crater diameter is 750um as
well.
The resulting crater diameters are plotted versus expo-
sure time in Figure III.5, and thus represent a time history
for crater formation. For all laser powers, the crater diame-
ter approached the spot diameter as the exposure time in-
creased, with the spot diameter being reached at shorter
exposure times for higher laser powers. The full spot diame-
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ter was never reached for laser powers of 2.5W even for the
longest time exposure investigated.
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Figure 111.5
Crater diameter versus exposure time for
single exposures with a 750um spot diame-
ter and various laser powers.
The resulting crater depths are plotted in Figure III.6.
For all laser powers, the crater depth increased linearly with
exposure time, indicating a constant ablation velocity. In
all cases, ablation velocity increased with laser power.
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Figure 111.6
Crater depth versus exposure time for sin-
gle exposures with a 750um spot diameter
and various laser powers.
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111.3.2 Variation
Diameters
in Ablation Rate with Varying Spot
The existence of a laser spot diameter dependence on the
rate of tissue ablation and crater formation was examined by
producing craters using single laser exposures at 5.0W.
Craters were made with several different exposure times using
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shielded devices with spot diameters of 250um, 500um, 750um,
and 1000um.
The craters produced were likewise relatively free of
char at all spot diameters and exposure times, with some
noticeable increase in char production at larger spot diame-
ters and longer times. Histology was similar in appearance of
that shown in Figure III.4. Qualitatively, the thickness of
the layers of vacuolation and collagen alteration decreased
with decreasing spot diameter at the same exposure time and
with decreasing exposure time at the same spot diameter.
The resulting crater diameters are plotted versus expo-
sure time in Figure III.7. For all spot diameters, the crater
diameter approached the spot diameter as the exposure time in-
creased, with the spot diameter being reached at shorter expo-
sure times for smaller spot diameters.
The resulting crater depths are plotted in Figure III.8.
For all spot diameters, the crater depth increased linearly
with exposure time, indicating a constant ablation velocity.
In all cases, ablation velocity decreased with increasing spot
diameter.
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Figure 111.7
Crater diameter versus exposure time for
single exposures at 5.0W and and various
spot diameters.
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Figure III.8
Crater depth versus exposure time for sin-
gle exposures at 5.0W and various spot
diameters.
111.3.3 Variation in Ablation Rate with Repeated Exposures
The effect of multiple laser exposures at the same tissue
site was examined by producing craters using 10OW/35ms expo-
sures and 10OW/63ms exposures, both using a device with a 500um
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spot diameter. Craters were made using from one to five
exposures.
All resulting craters were relatively free of char. His-
tology was similar in appearance of that shown in Figure
III.4, with an almost total absence of vacuolation and col-
lagen alteration due to the short exposure times and high
laser power. A typical histological section is shown in Fig-
ure III.9.
All crater diameters were equal to the spot diameter of
500um. The resulting crater depths are plotted versus the
number of exposures in Figure III.10. For both exposure
times, the crater depth increased linearly with the number of
exposures, again indicating a constant ablation velocity even
with multiple exposures.
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Figure III.9
Typical histological section through an
ablated crater. Photon dose for this
crater was 10W/63ms, and a 500um spot
diameter was used.
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Figure III.10
Crater depth versus number of exposures
for photon doses of 10OW/35ms and 10OW/63ms
and a spot diameter of 500um.
III.4 DISCUSSION
The small variability in crater diameter and depth with
any given combination of power, time, and spot diameter il-
lustrates the consistency of laser ablation using a scheme
capable of precisely controlled delivery of laser light. This
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Spot
Diameter
(um)
250
500
750
1000
750
750
750
750
Intensity Startup
Time
(W/mm2 ) (msec)
_ _ _ _ _ _ _ _ _ - - - - - - -
102
25.5
11.3
6.37
5.65
11.3
17.0
22.6
250
200
200
600
>1000
200
25
25
Ablation
Velocity
(mm/sec)
2.80
2.73
1.42
0.87
1.05
1.42
2.43
2.56
Table III.1
Observed practical threshold exposure
times, t, and penetration velocities, v.
short exposures can be used to limit tissue removal to small
incremental volumes, but the diameter of the craters created
will be roughly equal to the spot diameter with a substantial
degree of certainty. Exposure times can be increased easily
with an increase in the depth of the crater being the only
result.
The crater depth measurements shown in Figures III.6 and
III.8 show that in each case depth increases linearly with ex-
posure time up to the point of perforation. This indicates
that after ablation begins, the process proceeds at a constant
rate, with a constant ablation velocity, over the entire time
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Laser
Power
(W)
5.0
5.0
5.0
5.0
2.5
5.0
7.5
10.0
SINGLE FIBER SHIELDED DEVICE BEHAVIOR
DISCUSSION
consistency also indicates that a quantitative understanding
of the ablation process is realizable, and it is possible to
predict with some degree of accuracy not only how much tissue
will be removed by a given laser exposure, but the geometry of
the crater that is formed as well.
There are several important trends in the data itself.
Consider first the curves of crater diameter versus exposure
time for single exposures, shown in Figures III.5 and III.7.
As exposure time increased, crater diameter approached the
spot diameter. Also, as intensity increased, due to either an
increase in laser power or an decrease in spot diameter,
crater diameter approached spot diameter more rapidly. Table
III.1 gives the exposure times for which the crater diameters
reach 90% of spot diameter. The 90% diameter is useful be-
cause sample-to-sample crater diameter variations are much re-
duced at this exposure time. It thus may be thought of as a
practical threshold for producing reproducible craters.
Together, the trends in crater diameter indicate that it
may be desirable to design a laser catheter system to employ
high intensities, by the use of high laser powers and/or the
use of small spot sizes, to exploit the reproducibility of
crater diameters over the practical threshold. In this way,
as long as the time exposure is above the practical threshold,
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course of crater formation. It also suggests that the removal
rates for fibrous plaque and normal arterial wall are similar,
since no change in ablation velocity was noted as the crater
progressed from plaque to media. Ablation velocity also in-
creased with increasing intensity, brought about either by an
increase in laser power or a decrease in spot diameter. The
ablation velocity, calculated as the average slope of each
curve, are also listed in Table III.1.
From these results, it is possible to form a picture of
the time history of tissue ablation and crater formation (see
Figure III.11). Ablation begins at the center of the laser
spot, at or near the tissue surface. Immediately, the bottom
of the crater moves downward into the tissue at a constant
velocity. At the same time, the diameter of the crater
rapidly reaches the diameter of the laser spot.
A constant ablation velocity was also indicated when mul-
tiple exposures were made at the same tissue site, as shown in
Figure III.10. The fact that crater depths in Figure III.10
do not extrapolate to the origin may indicate that the tissue
is initially altered (eg, denaturation, dehydration, slight
char formation) during first exposure, causing more tissue to
be removed during that exposure than those that follow.
Likewise, crater depths shown in Figures III.6 and III.8 do
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gins in center
fs to equal spot diameter
,h increases linearly
Figure III.11
A schematic visualization of the time
course of tissue ablation and crater for-
mation. Ablation begins at the center of
the laser spot. As the crater forms, its
diameter increases to that of the laser
spot, and its depth increases at a con-
stant rate.
not extrapolate to the origin, indicating that this alteration
probably takes place at the onset of ablation early in the ex-
posure. However, after the first exposure, the ablation pro-
cess is purely additive. This consistent, additive nature of
ablation makes possible a precise, incremental removal of
tissue by the formation of small, shallow nibbles.
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Exposure times for which the first perceptible spot of
tissue is removed (an "absolute threshold") were found to vary
greatly from tissue sample to sample, and are therefore of
little clinical value.
The experiments performed here were not designed to give
accurate information about the absolute thresholds for tissue
ablation. For the successful design of a multifiber catheter
system, the practical threshold is a much more important
value. They likewise were not designed do give complete in-
formation about the peripheral damage produced using a single
fiber device. For the purposes of this thesis, that informa-
tion was obtained from multifiber device experiments presented
later. However, absolute threshold determination may be im-
portant in fully understanding the laser/tissue interaction as
ablation begins. An effort to extend the work presented in
this section to investigate the absolute thresholds, and to
characterize the peripheral damage and ablation yield using
single fiber shielded devices has been undertaken by Sipke
Strikwerda in a collaborative effort at the Cleveland Clinic
Foundation [1]. Farooz Partovi, a member of the Laser An-
giosurgery Group at MIT, is currently investigating the rela-
tionship between that data and a theoretical model for tissue
ablation.
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SECTION IV
LASER/TISSUE INTERACTION
IV. 1 OVERVIEW
A simple model of thermal ablation of tissue using laser
irradiation is presented. A relation for the ablation velo-
city is developed using the heat equation and energy conserva-
tion arguments, evaluated as pseudo-steady state in a moving
reference frame. Although a complete development of a thermal
ablation model is beyond the scope of this thesis, and could
be in fact a thesis in and of itself, the relations derived
here point out the important parameters that govern the
laser/tissue interaction. Ablation velocities predicted by
the model are compared with those measured in Section III. A
comparison of the theory with multifiber device experiments
will be presented in the sections describing those experi-
ments.
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An extension of the model presented here is currently
under development by members of the MIT Laser Angiosurgery
Group [1].
IV.2 REVIEW OF ABLATION MODELS
Although the use of laser radiation is becoming routine
in surgery to cut and remove tissue, theoretical modeling of
the laser ablation process has until recently received rela-
tively little attention. A quantitative understanding of tis-
sue removal is particularly important when precise ablation
and control of the geometry of the ablated volume is neces-
sary, as in laser angiosurgery. The formation of craters
which are consistent in size and geometry, demonstrated in the
last section, indicates that a quantitative, theoretical
description of tissue ablation is possible.
When continuous lasers are used for tissue removal, with
intensities on the order of tens to hundreds of watts per
square millimeter and exposure times of tens of milliseconds
or longer, the ablation process is largely thermal in nature.
Tissue removal is largely brought about by vaporization of
tissue water. This is distinct from tissue removal by other
proposed laser mechanisms, such as excimer laser
photodecomposition [2,3], and pulsed laser ablation [4-6] and
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explosive fragmentation [7], all of which use light of much
shorter pulse widths and much higher peak powers.
A relatively large literature exists on the subject of
non-ablative heating of biological materials [8-11]. However,
relatively little theoretical information has appeared on
thermal ablation. Complications which make thermal ablation
difficult to describe theoretically include the abrupt change
in thermal behavior of tissue as it is heated to its ablation
temperature, the simultaneous occurrence of heat flow and mass
removal, and the difficulties associated with describing the
distribution of light in a scattering medium. Wolbarsht [12]
stressed the importance of using laser wavelengths with large
absorption in tissue to minimize the extent of damage in the
surrounding tissue. Laufer [13] presents a one-dimensional
ablation model, where the heat of ablation is treated artifi-
cially by allowing the temperature to rise above the ablation
temperature. He does not, however, account for light scatter-
ing. Langerholc [14] incorporates vaporization and scattering
in the model he describes, but the treatment is again
one-dimensional and emphasizes the distribution of light
rather than the removal of material. Van Gemert [15]
presented a numerical model of thermal ablation, emphasizing
the startup of the ablation process. The treatment includes
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heat diffusion in three dimensions but restricts the light to
the beam cylinder within the tissue.
The literature also includes a limited amount of ex-
perimental work aimed at a basic understanding of the ablation
process. Welch [16] presents evidence from thermal camera
studies that ablation temperature commonly exceed 1000 C, and
may reach as high as 300 0C. Rastegar [17] has demonstrated
with agar gel experiments the effects of varying absorption
coefficients on the ablation process. The single fiber
shielded device experiments described in the last section form
a significant addition to the experimental work in this area.
A related literature concerns thermal ablation of metals
and other materials for cutting, welding, and materials pro-
cessing [18]. However, ablation in tissue differs signifi-
cantly in that light scattering plays a significant role,
contrasted to materials processing where scattering is usually
negligible compared to absorption. Also, the ratio of
specific heat to latent heat of vaporization in water is much
higher than those for most industrial materials. Nonetheless,
a relevant treatment is presented by Bertolotti [19], where he
uses the "heat balance integral method" to study the melting
front produced in silicon by an internal heat source. That
approach will be used here as well.
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A theory of laser ablation which avoids many of the
problems discussed in the literature is presented here.
First, the complexities of light scattering is avoided by as-
suming a known light distribution function within the tissue.
Second, the chemical changes taking place in the tissue are
ignored. The removal process is regarded as being brought
about by the evaporation of tissue water. Third, the ablation
problem is treated as pseudo-steady state in a reference frame
moving with the ablation front.
IV.3 PRINCIPLES OF THE PSEUDO-STEADY STATE APPROACH
The following theoretical analysis is limited to the si-
tuation where the ablation process has reached pseudo-steady
state, i.e., crater formation progresses at a steady rate
governed by the ablation velocity.
The linear increase in crater depth for all incident
power levels at all exposure times, found in the single fiber
experiments just described, implies that pseudo-steady state
is reached early as ablation proceeds. Therefore, a
pseudo-steady state approach is likely to describe the bulk of
the ablation process without the added complication of
describing the transient startup.
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Figure IV.1 depicts ablation and crater formation at an
arbitrary instant in time after pseudo-steady state has been
reached. For simplicity, a collimated beam has been assumed
to irradiate the tissue from above, and a cylindrically sym-
metric geometry has been employed.
As laser light reaches the bottom of the crater, it is
distributed within the tissue where it is scattered and ab-
sorbed by tissue chromophores. Energy that is deposited by
absorption transfers rapidly by thermal conduction to the tis-
sue water. As energy accumulates, the tissue water is heated
to its vaporization temperature (Tvap). As energy further ac-
cumulates, a region forms in the tissue, labelled the T re-
vap
gion, which has reached the vaporization temperature but has
not accumulated the latent heat of vaporization (H ) neces-
vap
sary to ablate that volume. Energy can be thought of as
stored within this volume by the formation of tiny pockets of
interstitial steam. Finally, as Ha p is accumulated, tissue
ablates at the bottom of the crater.
Note that the diameter of the forming crater must be
equal to that of the incident laser beam. Since the laser in-
tensity must be most intense in the tissue directly at the
crater's bottom, that tissue must receive energy most rapidly
and thus must ablate first. Before it is ablated, tissue
- 62 -
LASER/TISSUE INTERACTION
PRINCIPLES OF THE PSEUDO-STEADY STATE APPROACH
beam
diameter
(d)
laser
beam
..... ... t i ss: :::: :,: ,: 
direction v locity
direction (r)
.... .................:::::::::::::: 
z=zvap necessar
........... ... ....... i
state ablation of tissue. The region of
tissue labeled T a has been heated to the
lated the heat of vaporization necessary
for ablation.
- 63 -
LASER/TISSUE INTERACTION
PRINCIPLES OF THE PSEUDO-STEADY STATE APPROACH
radially peripheral to it may have accumulated energy scat-
tered into it. However, after it ablates, that tissue no
longer receives scattered light and H cannot be accumu-
vap
lated. Conversely, if the crater had a diameter smaller than
the laser beam, laser light would continue to deposit energy
in the remaining tissue until it was vaporized.
This description of the ablation process depends upon the
assumption that tissue water with its large heat capacity and
heat of vaporization is the primary heat sink for the laser
energy, and that ablation is equivalent to vaporizing that wa-
ter. Once the tissue water has been vaporized, any remaining
organic material may continue to absorb heat, rising in tem-
perature above Tvap as it undergoes carbonization and pyro-
lysis. This fact, in addition to the possibility of
superheating of the tissue water due to the generation of high
pressures within the tissue, may help account for the observed
ablation temperatures above 100°C which have been reported
[16]. The energy involved in this process, however, is prob-
ably small compared to that necessary to vaporize the tissue's
water.
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IV.4 THEORETICAL MODEL
In the arrangement depicted in Figure IV.1, a collimated
beam of laser light having a uniform profile and circular
cross section and propagating along the z-axis is incident
upon a tissue sample. The sample is assumed to be homogeneous
and infinite in extent.
The conductive transfer of heat within the tissue is
described by the equation of thermal conduction,
dtT(r,z,t) = kV2T(r,z,t) + 1 S(r,z,t) (1)d PCp
where cylindrical coordinates have been used to exploit the
symmetry of the problem. The temperature distribution is
represented by the function T(r,z,t), a function of space and
time. The heat source term, S(r,z,t), denotes the power den-
sity absorbed from the laser beam by the tissue. The tissue's
density and thermal parameters are assumed to be constant, and
are defined:
Q = density
C = heat capacity
k = thermal diffusivity
We shall look at the ablation process from a coordinate
system moving with the ablation front, i.e., with the bottom
of the crater. This allows us to make some simplifications to
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equation (1) to take advantage of the pseudo-steady state as-
sumption. The laboratory coordinate system, (r,zlab,t),
be transformed into the moving frame, (r,z,t), by
relations:
z= Zlab - l(t); v = dl(t)dt
where l(t) is the depth of the ablated crater at time t, and v
is the ablation velocity.
transformed
The heat diffusion equation is
into the moving coordinate system by the
transforming derivatives:
d = (d)
dzlabt dz)tZlab
(d d v(d
dt zlab dt z dz) t
After transformation, the heat equation becomes:
dtT(r,z,t) = dT(r,z,t) + kV2 T(r,z,t) + 1 S(r,z,t)d Et v3z C C 
(3a)
(3b)
(4)
Also, since the heat flow equation (4) is not effected by ad-
ding a constant to T, we will define all temperatures relative
to the ambient tissue temperature.
In the pseudo-steady state regime, equation (4) reduces
to:
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o = vd-T(rz) + kV 2 T(r,z) + 1 S(r,z) (5)
o z 'cP
where the time derivative has been eliminated, and T(r,z) is
now a function of space only. Any changes in the optical tis-
sue parameters with increasing temperature are ignored,
resulting in a heat source term, S(r,z), which is likewise
space dependent only.
Two regions have been defined within the tissue. The
Tvap region surrounds the crater and is bounded on the outside
by the T boundary. All tissue within this region is at the
vap
ablation temperature. The rest of the tissue outside of this
region is at a temperature less than Tvap
.
The temperature
distribution in the Tvap region is the trivial one:
T(r,z) = Ta p (6)ya
To find the solution outside, the heat equation (5) must
be solved, subject to the unusual boundary condition that both
the temperature (equal to T ap ) and its gradient (equal to
zero) be specified at the unknown, moving T boundary. In
vap
the pseudo-steady state regime, the energy source term, the
location of the Tvap boundary, and the temperature
distribution are all time independent, fixed relative to the
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coordinate system which is moving at a constant velocity equal
to the ablation velocity. There still exists the unconven-
tional boundary condition: "find a boundary surface such that
if the temperature on it is assigned to be Tvap, then the tem-
perature gradient on it will come out zero". The other boun-
dary condition is at the far away points where T = 0 (where T
has been defined relative to the ambient body temperature).
The solution of equation (5) will be a function of the
ablation velocity (v), which appears in that equation. As we
shall see later, the requirement of energy conservation can
then be used to fix v.
Equation (5) can be solved numerically to find the tem-
perature distribution in the tissue surrounding the forming
crater. At this time, however, we will use energy conserva-
tion arguments and plausible approximation to estimate the ab-
lation velocity. This will in turn furnish information on the
fraction of laser energy that is lost to the surrounding tis-
sue.
Let us focus our attention on the ablation cylinder
(shown in Figure IV.1 bounded by dotted lines). This is an
infinite cylinder of tissue, of the same radius as the in-
cident laser beam, that would eventually be ablated, an
imaginary extension of the laser beam into the tissue. The
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top of the cylinder, bounded by the crater bottom at z = 0 and
the Tvap boundary at z = Zvap, will be referred to as region
1. The rest of the ablation cylinder, z > Zvap ' will be
called region 2. Note that the crater bottom and the section
of the Ta p boundary making off region 1 are assumed flat.
The source function, S(r,z), represents the power ab-
sorbed from the laser beam by a unit volume of the tissue at
the point (r,z). Its integral over the volume of the tissue
will yield the total power delivered to the tissue:
21t (r dr (dz S(r,z) = P (7)
This "P" is the total power in the incident laser beam, cor-
rected for the power loss from the surface due to reflection.
With a beam diameter (d) and uniform beam profile:
d2
P -T I (8)
where I is the beam intensity.
The source function is in general a complicated function
of the beam diameter and the absorption and scattering coeffi-
cients of the tissue. It may also depend on the relative
index of refraction at the tissue surface. Its correct
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functional form is the subject of many theoretical as well as
experimental investigations [14-16].
We will not be concerned with finding a rigorous source
function, S(r,z), in this work. Instead, we will use the fol-
lowing sample function to demonstrate how it can be used to
calculate the quantities of interest. This function assumes
that a fraction of the light within the ablation cylinder is
deposited within the tissue, and that the beam intensity
decreases exponentially in z:
S(r,z) = c' I exp(-z); r < d (9a)D 2
where ' is the effective absorption coefficient, and D is the
penetration depth, i.e., the characteristic depth over at
which light is reduced in intensity by l/e due to the inter-
play of scattering and absorption. Likewise, a fraction of
the light outside of the ablation cylinder is also deposited
within the tissue, but in this case the beam intensity falls
off exponentially in z and in r as the penetration depth, and
falls of as l/r due to the cylindrical geometry:
S(r,z) = K' I exp(- 5) d exp(/) exp(-5); r > (9b)A more sophisticated function can always be substituted,
A more sophisticated function can always be substituted,
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although this may make the following integrals more difficult
to evaluate.
Note that the penetration depth is strongly wavelength
dependent because light absorption is tissue is a highly vary-
ing function of wavelength.
Equations (8) and (9), taken together, can be thought of
as a normalization condition that requires that:
=- f(d); f(d) = d (10)D d + 4D
relating the effective absorption coefficient to the penetra-
tion depth and the beam diameter. The parameter f(d) is the
fraction of light contained within the cylinder of tissue, of
diameter d, which will be ablated. The rest of the light is
lost to the surrounding tissue through scattering.
To get an energy balance equation for region 2, equation
(5) is integrated using the source function described in equa-
tions (9) and (10). This yields:
0 = -Q + - vh 0 + f(d) I exp(-) (11)
where Q is the total heat diffusing out of region 2 per unit
time, and h0 is the energy required to raise a unit volume of
tissue from the ambient body temperature to Tvap:
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h0 = CpTvap (12)
This result can easily be interpreted physically. In the
pseudo-steady state regime, the accumulation of energy (equal
to zero) is equal to the loss of energy through the boundaries
of region 2 by thermal diffusion, plus the loss of energy due
to heated tissue crossing! the Zvap boundary into region 1,
plus the energy gained through absorption of energy from the
laser beam.
Likewise, a similar energy balance holds for region 1:
0 vHvd + d vhd + I (1-exp(- (13)4 vap 4 0 F D
Note that no heat escapes this region by diffusion because
there is no thermal gradient; no Q term appears in equation
(13). The physical explanation of this equation is similar to
that of equation (11). The accumulation of energy (equal to
zero) is equal to the loss of energy due to tissue ablation
leaving region 1 (-vH vap ), plus the energy gained due to hot
tissue entering region 1 (vh0) and through absorption of
energy from the laser beam.
Equations (11) and (13) can be solved to yield the steady
state ablation velocity (v):
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v f(d) (I - 4Q (14)
ho+Hvap f(d)Td2
and the depth of the Ta p region (z vap):
ap H v ap
1 + h
zp = D ln( H (15)
1 + yap 4Qho f(,d)ld2I
The quantity Q appearing in these equations, although
time independent, is an unknown function of I, that will be
known only if the pseudo-steady state heat equation (5) is
solved and the temperature distribution is used to calculate
the heat flux leaving region 2. To get an approximate value
for Q, we expand it in a Taylor series about I = Io0 the
threshold intensity for tissue ablation, and keep only the
first term:
Q = Q(I) = Q(I 0) (16)
This is a reasonable approximation, because roughly speaking,
heat flux out of region 2 depends on the temperature distribu-
tion in this region relatively to the ambient tissue tempera-
ture. The highest temperature in this region is Tvap, no
matter what the intensity. Hence, greater intensities should
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result in greater ablation velocities but not appreciably dif-
ferent temperature distributions in region 2.
With the assumption (16), Q can be calculated from either
equation (14) or (15), setting v or zvap to zero:
Q= 4 f(d) I (17)4 0
Equations (14) and (15) can be combined with equation
(17) to give the final relations:
v = f(d) (I-I0) (18)
h0+Hvap 
H
1+ ap
Zvap D ln( H I (19)
1 + yap 0ho I
To calculate the crater depth (1) produced by a given ex-
posure, we need to make the approximation that the
pseudo-steady state ablation velocity is reached immediately
after ablation begins, and that ablation begins after a short
startup time to:
1 = v(t-t 0 ) = T(d) (I-I 0 ) (t-t) (20)
0va p
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An ablation efficiency can be calculated from the above
results, to gain insight into the most efficient combination
of ablation parameters. The ablation efficiency ( ) is equal
to the ratio of the energy used to ablate tissue to the energy
absorbed by all the tissue:
2
I t
=4- 1 (h 0+Hvap ) =f(d) (1 i ) to) (21)
-It
The above theoretical model of the ablation process has
been extended [1] to include calculation of the startup
parameters. The undetermined parameters I0 and t in the
above relations were estimated in that work to be:
2 C kTva
(H vap+h ) D
0 f(x) I(23)
IV.5 DISCUSSION
For the purposes of illustration, physical constants
present in the above equations will be taken to be equal to
those of water, and are listed in Table IV.1. In particular,
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Tvap will be taken to be the boiling point of water minus
normal body temperature, Ta p =100-37 = 630C. The penetra-
tion depth of argon ion laser light in tissue will be taken to
be D = 1/3mm, consistent with the findings of van Gemert for
the absorption and scattering coefficients for human aorta
[20].
Sym
Tv
ho= C
Hv
lbol
_ _ 
Definition
_--_______
Val
Cp heat capacity 0.00396J,
per unit volume
k thermal diffusivity 0.106m
boiling point 63°
ap relative to ambient
D penetration depth 1/3
for argon ion laser
pTvap energy needed 0.25J,
to heat unit volume
to Tvap
latent heat 2.25J,
of vaporization
Table IV.1
Definitions and values of the physical
parameters used.
ue
/°Cmm3
m2/s
C
mm
/mm3
A characteristic time over which thermal diffusion ()
takes place can be estimated using the thermal diffusivity of
water (k) and taking the characteristic length of the thermal
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gradient to be the penetration depth of laser light (D) in the
relation:
2 2
2 = D (1/3) = l.ls (24)
k 0.106
Equation (24) suggests that thermal diffusion may not
play an important role in the ablation process for exposure
times much less than one second. In equation (18), the loss
of energy due to thermal diffusion is accounted for by sub-
tracting the threshold intensity (Io) from the incident inten-
sity (I). In the absence of thermal diffusion, or in the
limit where thermal diffusion is unimportant because of high
intensities and high ablation velocities, equation (18) would
simplify to:
v f(d) I (25)
ho+Hvap
In equation (25), the ablation velocity (v) is equal to the
incident intensity (I) divided by the total energy necessary
to raise a unit volume of tissue to the vaporization tempera-
ture (h0) plus the latent heat of ablation (Hvap). This same
result can be obtained through a simple energy balance on the
volume of tissue ablated.
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The single fiber ablation experiments described in Sec-
tion III measured ablation velocity as a function of incident
laser power and spot diameter. The results of those experi-
ments are reproduced in Table IV.2.
Experiment
Number
1
2
3
4
5
6
7
8
Laser
Power
(W)
5.0
5.0
5.0
5.0
2.5
5.0
7.5
10.0
Spot
Diameter
(um)
250
500
750
1000
750
750
750
750
Intensity
(W/mm 2 )
102
25.5
11.3
6.37
5.65
11.3
17.0
22.6
Ablation
Velocity
(mm/sec)
2.80
2.73
1.42
0.87
1.05
1.42
2.43
2.56
Table IV.2
Observed ablation velocities, v, repro-
duced from the single fiber ablation ex-
periments in Section III.
Equation (25) predicts that the ablation velocity (v)
should proportional to the laser intensity (I) for I > Io,
with the proportionality constant equal to f(d)/(h0+Hvap) . If
the quantity v/I is computed for each experimental value of v
in Table IV.2, an experimental value for the proportionality
constant can be obtained. Then taking h+Hvap to be equal to
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2.5J/mm3 , an experimental value for f(d) can be computed. The
results of those computations are shown in Table IV.3.
Experiment
Number
1
2
3
4
5
6
7
8
Intensity Ablation
2 Velocity
(W/mm2 ) (mm/sec)
102
25.5
11.3
6.37
5.65
11.3
17.0
22.6
2.80
2.73
1.42
0.87
1.05
1.42
2.43
2.56
Table IV.3
Computed
from the
values for f(d)/h0+H and f(d)
intensities used an8P ablation
velocities observed in the single fiber
ablation experiments in Section III.
The average value for f(0.75) (experiments 5-8) can be
calculated to be 0.36. Taking the form of f(d) to be given by
equation (10), with d = 0.75mm, the value for the penetration
depth, D, can be calculated to be 0.33mm, which is in good
agreement with the 1/3mm, consistent with the findings of van
Gemert for the absorption and scattering coefficients for
human aorta [20].
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ho+Hvap
0.028
0.107
0.126
0.137
0.186
0.126
0.143
0.113
f(d)
0.07
0.27
0.32
0.34
0.47
0.32
0.36
0.28
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Table IV.4 shows the predicted ablation velocities using
equation (25) and the values listed in Table IV.1.
Experiment
Number
1
2
3
4
5
6
7
8
Experimental
Ablation
Velocity
(mm/sec)
2.80
2.73
1.42
0.87
1.05
1.42
2.43
2.56
Predicted
Ablation
Velocity
(mm/sec)
6.52
2.75
1.63
1.10
0.82
1.63
2.45
3.25
Observed
ties.
Table IV.4
and predicted ablation veloci-
Predicted ablation velocities are in relatively good
agreement with those observed in the single fiber ablation ex-
periments, with the obvious exception of experiment 1 using a
250um spot diameter. It is quite possible that our simplistic
form of f(d) does not give a good results for very small spot
diameters.
The single fiber ablation experiments of Section III were
not designed to provide information about absolute threshold
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times or threshold intensities. Comparison of practical
thresholds and theory would be of limited value, since it is
not clear how practical threshold times relate to the to
threshold time defined in equation (23). However, since equa-
tion (23) defines the time required before any ablation takes
place, we would expect practical thresholds to be longer than
that time. In fact, the practical thresholds are longer by a
factor of two to five for all but the experiments where 7.5W
or 10W were used. In this case, the practical threshold was
much less than t0o.
Some preliminary experiments performed in this lab have
indicated that the penetration depth, D, may change drama-
tically with tissue heating and the onset of ablation, tending
towards a value much less than 1/3mm. This may be due to
creation of a thin layer of char on the tissue surface or as a
result of tissue dehydration or heating directly. It is quite
possible that such a dramatic change in the penetration depth
reduces the threshold times for ablation dramatically as well,
since t is such a strong function of D.
Equation (19) gives the depth (z vap ) of the the Tvap re-
gion below the crater. After the laser beam has been turned
off, a thickness of Zvap of tissue at the bottom of the crater
has been heated to Tvap
.
This region has been heated to a
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temperature capable of damaging the tissue through the forma-
tion of pockets of steam and coagulation of tissue proteins.
In addition, it may be the source of energy which may damage
surrounding tissue as the energy in the T region dis-
vap
sipates. The maximum value for Zvap is:
Zvap = D ln(l + 0 ) = 1/3ln( + 25 = 76mm (26)
The zones of vacuolation damage found to surround the craters
created in the single fiber experiments were actually much
smaller than that. This would indicate that the Ta p region
may not extend as deep as predicted. Again, this may be due
to changes in the penetration depth, D, as ablation proceeds,
causing the laser light to penetrate less deeply in the tissue
and producing a smaller damage region.
Equation (21) describes the efficiency () of the abla-
tion process as a function of the beam diameter (d), the in-
cident intensity (I), and the exposure time (t). Note that
the efficiency increases with increasing intensity and with
increasing exposure time. The production of deep craters
(long exposure times and/or high ablation velocities) is more
efficient than shallow craters. However, as pointed out
above, I0 is expected to be small. The production of craters
at very short exposure times, found in the single fiber ex-
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periments, indicates that the threshold time (t0) is small as
well. Equation (21) can be approximated by:
= f(d) = d (27)
Note that as the penetration depth (D) decreases, i.e., as the
tissue absorption for the laser wavelength used increases, the
efficiency increases, approaching a limiting value of unity.
Likewise, as the beam diameter increases, scatter becomes less
and less important, and again the efficiency approaches unity.
Although the ablation efficiency can be thought of as a
measure of the fraction of energy that goes into ablation
verses the fraction that simply damages the peripheral tissue,
it is important to note that this definition is somewhat
misleading. As ablation proceeds at steady state, the size of
the Tap region surrounding the bottom of the hole is deter-
mined by the tissue properties, and not by the exposure time
or laser intensity, as shown in equation (19). When the laser
is turned off, the region of peripheral damage is likely to be
related to the size of this T region.yap
In summary, the simple model described here points out
the important parameters that define the ablation process,
namely laser intensity, laser exposure time, laser spot
diameter, penetration depth, and the specific heat and heat of
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ablation of the tissue. The model predicted ablation veloci-
ties relatively well using the properties of water and a value
of the penetration depth reported in the literature. However,
the model also points out some definite short comings. It is
clear that a better understanding of the penetration depth and
how it changes is necessary before a more accurate model can
be developed. A better understanding of the light distribu-
tion within the tissue both before and during ablation may al-
low the formulation of a better relation for f(d). This model
has made no attempt to account for the spreading of the in-
cident laser beam inherent in optical fiber delivery. Further
refinement of the model to address some of these problems is
being undertaken by members of the Laser Angiosurgery Group
with the addition of a large body of single fiber device data
provided by collaborators at the Cleveland Clinic Foundation.
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SECTION V
MULTIFIBER LASER ANGIOSURGERY SYSTEM DESIGN
V.1 OVERVIEW
Based on the results of the single fiber shielded device
experiments presented in Section III, the important concepts
and considerations in the design of a multifiber shielded
laser catheter are presented. The catheter design, and the
optical system and computer based control system which support
it are described in full. Experiments which fully charac-
terize the ablation process using this system will be
presented in the following two sections.
V.2 MULTIFIBER SHIELDED CATHETER DESIGN CONCEPTS
Successful recanalization of obstructed arteries requires
that ablation proceed in a controlled and predictable way,
that the catheter open a lumen of sufficient diameter to re-
store normal blood flow through the artery, and that the
artery is not damaged by the ablation process in such a way
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that it does not provide a good conduit for blood flow.
Through the use of controlled laser light delivery afforded by
a transparent optical shield, controlled and consistent abla-
tion of atheromatous plaque and artery tissue was demonstrated
using a single fiber shielded device in Section III. The same
concepts employed in the design of that single fiber device
can be extended to produce a catheter capable of save recanal-
ization of arteries in vivo.
The strategy used to design the angiosurgery catheter was
to combine many small craters, all produced by single indepen-
dently targeted optical fibers, to produce a single large com-
posite hole. This can be accomplished by including an array
of fibers together inside an optical shield, and firing them
one at a time, in rapid succession.
It is absolutely necessary that the individual craters
produced by individual fiber exposures overlap with their
nearest neighbors to insure that all of the tissue in the
catheter's field of view can be vaporized. It is also neces-
sary to completely cover the forward surface of the optical
shield, since a lumen as large as the shield diameter must be
created into which the catheter can advance. This allows the
shield to remain in contact with the tissue to be vaporized,
maintaining controlled light delivery.
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Although the multifiber design adds to the complexity of
the angiosurgery system and catheter, it contributes some im-
portant advantages as well. First, a large lumen can be
created in an obstructed vessel using modest powers readily
available using argon ion lasers or other continuous laser
systems (5W to 10W), while keeping the intensity very high
(kilowatts per square centimeter) and allowing for short expo-
sures. The single fiber experiments of Section III indicated
that high intensities produced less charring of the tissue
lining a crater, and allowed for very short time exposures
while remaining above the practical threshold for consistent
ablation. Second, sequential firing of the fibers in the ar-
ray allows a low average power to be used (5W to 10W, reduced
by the time the laser is off in between exposures). Since all
energy delivered to a lesion must be dissipated by the sur-
rounding tissue, this reduction in average power may be impor-
tant to reduce thermal damage to the tissue not ablated.
This design also adds the possibility of selective
removal of diseased tissue, without unnecessary exposure of
blood or undesirable ablation of media underlying an atheroma.
Prototype 8F (2.5mm) multifiber shielded catheters were
designed and characterized to demonstrate these design
concepts. The findings of those studies will be presented in
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the following sections. In addition, a smaller 4.5F (1.5mm)
catheter has also been developed for use in smaller vessels
[1]. This device employed the same design concepts
demonstrated by the larger catheter.
V.3 DESCRIPTION OF THE MULTIFIBER CATHETER
Several 8F (2.5mm outer diameter) multifiber shielded
catheters were constructed for use in the following experi-
ments. The distal end consisted of a transparent, rounded
quartz shield encasing 19 Spectraguide 422 optical fibers,
with core diameters of 105um and a numerical aperture of 0.29.
The quartz shield was formed from a short length quartz
tubing with a 3.0mm outer diameter and a 2.0mm inner diameter,
closed at one end with a torch to form a hemispherical end.
The outer diameter of the shield was then reduced to 2.5mm by
grinding and polishing (see Figure V.1).
The output ends of the fibers were polished and mounted
rigidly inside the shield in a hexagonal close-packed array
consisting of a central, axial fiber, surrounded by inner and
outer rings of six and twelve fibers, respectively. The
fibers were positioned so that the 19 spots of light exiting
the distal output surface of the shield formed an overlapping
pattern which completely covered that surface. This required
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output
surface
Figure V.1
Schematic diagram of the rounded shield
used in the 8F multifiber catheter.
that the fibers be angled, with the inner ring of fibers
oriented approximately 70 and the outer ring fibers approx-
imately 150 to the axis of the shield, and spaced approx-
imately 2.0mm from the shield's output surface (see Figure
V.2).
Light was coupled into each fiber in such a way that its
output beam fully filled the fiber's numerical aperture.
Diameters of the light spots created by the exiting laser beam
as it intersected the outer shield surface ranged from 800um
to 900um in diameter, with the twelve outer ring spots
generally being slightly larger than those in the center. A
map of the laser spots showing their overlapping pattern was
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optical
fibers
angled
output
array
(cut away) shield
catheter
body
I
20th fiber
terminated
in power meter
optical
fibers
(20) linearinput
array
Figure V.2
Schematic diagram of the multifiber
shielded catheter, showing the angled
orientation of optical fibers inside the
optical shield and the linear alignment of
the input ends of all optical fibers. The
output ends of the fibers are angled, with
the inner and outer ring fibers oriented
70 and 15 ° to the axis of the shield,
respectively. Note that an extra twen-
tieth optical fiber is also included in
the linear input array to be used to moni-
tor laser power.
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produced by imaging the catheter through
microscope, and is shown in Figure V.3.
A
a dissecting
B
Figure V.3
8F multifiber shielded catheter. A,
Photograph; B, Light spot pattern pro-
duced by the 19 optical fibers as imaged
through a dissecting microscope. Note
full coverage of the optical shield.
The input ends of the optical fibers were polished and
mounted rigidly in a linear array to allow rapid sequential
alignment with a linear translator under computer control (see
Figure V.3). A twentieth calibration fiber was also mounted
in the array, but terminated outside the shield, to use in
measuring delivered power. The body of the catheter was
formed by a 3m length of 2.5mm diameter PVC tubing.
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V.4 THE LASER ANGIOSURGERY SYSTEM
The entire ablation system can be thought of as divided
into three components: the multifiber laser catheter, the
optical components of the system, and the control components
of the system. Integrated together, they form an reliable and
flexible environment for the controlled ablation of tissue.
V.4.1 Optical Subsystem
Figure V.4 diagrams the optical path of the laser an-
giosurgery system.
Blue-green light from a Coherent Innova 20 or Coherent
Innova 100 argon ion laser was used as the laser source for
all experiments. When running all lines, these lasers are ca-
pable of 20W maximum output, TEM00 lowest order Gaussian mode,
with most of the power at 488nm and 514nm.
The output of the laser was first focused into a 20m
length of 50um core, graded index optical fiber cable with a
numerical aperture of 0.21. Its output was collimated and
focused sequentially onto each input end of the catheter's
fibers with a lens system matching their numerical aperture of
2.9. This coupling scheme helped excite high order modes in
the optical fibers to produce maximally diverging output beams
with fairly uniform intensity profiles. A typical optical
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lens
fiber
cable
collimating focusing power
calibration
fiber
or carlneer
Figure V.4
Schematic diagram of the laser angiosur-
gery optical path. The intermediate fiber
cable is used to help excite high order
modes in the optical fibers of the
catheter, producing maximally diverging
beams.
fiber output is shown in Figure V.5, as measured by a Reticon
linear diode array. In addition, the fiber cable provided a
means for locating the laser outside of the room in which the
procedure was taking place, thus isolating the operators from
the noise produced by the laser, freeing the space in the
procedure room for other uses, and making it possible for the
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same laser to be used in multiple procedure rooms without the
need to move it.
Figure V.5
Reticon linear diode array map of the in-
tensity profile of the center fiber of a
8F multifiber shielded catheter. A diame-
ter of 900um is indicated at the l/e
point. Approximately 85% of the laser's
energy will be inside this diameter.
V.4.2 Control Subsystem
Figure V.6 diagrams the control components of the laser
angiosurgery system.
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attenuator
(for 1-20 only)
r~~ I , I
safety polarizing half-wave
shutter prism plate
Figure V.6
Schematic diagram of the control com-
ponents of the laser angiosurgery system.
When using the Innova 20, the light was first passed
through an attenuator consisting of a halfwave plate and a po-
larizing prism. By rotating the halfwave plate, the polariza-
tion of the laser beam passing through it could be varied,
thereby changing the fraction of the light rejected by the po-
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larizing prism. The laser power could be adjusted in this way
from nearly 100% transmission of the laser output to a few
tens of milliwatts, without deviation or degradation of the
laser beam which might compromise optical alignment.
The Innova 100 laser has the means of regulating its out-
put power from 0.1W to 20.0W without the need for an attenua-
tor. In this case, the cpmputer communicated directly with
the laser to set and monitor its output power.
Laser power transmitted to the output face of the optical
shield was measured using a calibration fiber aligned with the
other 19 fibers at the proximal end of the catheter but ter-
minated in a thermal power meter accurate to +0.1W. The power
striking the tissue was about 8% lower due to reflections at
the shield surfaces.
Exposure times were controlled by a computer activated
Uniblitz SD-1000 shutter placed in the light path before the
proximal end of the catheter. Exposure times were accurate to
+2ms. Individual fibers were sequentially aligned by a Unidex
II linear translator under computer control. This translator
can accurately locate the input end of a fiber with 4um
resolution and +2um accuracy, with a maximum travel rate of
20cm/s. During operation, the computer instructed the
translator to align a particular fiber by translating to a
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stored location and then activated the shutter to expose, or
"fire", the fiber. Unless otherwise noted, there was an in-
terval of approximately 170ms between successive fiber expo-
sures. Normally, all 19 fibers were fired sequentially to
form a "round".
A failure detection system was designed to detect the un-
likely failure of fibers due, to breaks, misalignment, or con-
tamination of the output end inside the optical shield. Such
failures may endanger the operator or patient by allowing un-
controlled laser light escape from the catheter or by produc-
ing pressures within the shield sufficient to fracture it.
When an optical fiber fails, the laser light reaching the
site of the failure generates incandescent light at
wavelengths other than the 488nm and 514nm wavelengths of the
argon ion laser. A certain percentage of this light is
trapped within the optical fiber and conducted back to the
input end where it is collimated. A fraction of this light is
picked off by a glass plate acting as a beam splitter and
directed through a 570nm long pass filter to a detector. A
fiber failure such a break generates enough light at the
detector to produce a signal approximately ten times the back-
ground. The failure detection circuit has been designed to
close a safety shutter placed directly in front of the laser
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any time the signal is more than twice background. Time
response of the system has been measured at 15-20ms, limited
by the response of the mechanical shutter. This response time
is adequate to discontinue the firing of a single fiber under
most conditions, and will always prevent the firing of any
fiber after a failure.
The entire ablation system was controlled by a PDP 11/23+
microcomputer running Digital Equipment Corporation's RSX-llM
multitasking, multiuser, real-time operating system. A highly
optimized, highly flexible pushbutton program, called WILBUR,
was written specifically to run the ablation system. It was
designed to be "friendly" and robust enough to be used by med-
ical or research personnel with a minimum of computer experi-
ence, flexible enough to adapt to the changing demands that
experiments demanded, yet fast to use to allow the operator to
operate the system in an in vivo environment where quick
response is required. Figure V.8 shows the WILBUR screen at
top level and during the firing of a round.
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attenuator
(for 1-20 only)
safety polarizing half-wave
shutter prism plate
Figure V.7
Schematic diagram of the full laser an-
giosurgery system.
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WUILBUR V5. 2
Date: 07-JUN-87 Tie: 20:15:33
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Figure V.8
Screen dump images of the WILBUR laser an-
giosurgery control program at top level
and during firing. Note that all impor-
tant operating parameters are displayed
continuously, except laser power which un-
available when using an I-20 laser. Pro-
gram functions are accessed through the
keypad of a VT100 terminal, which is drawn
on the right had side of the screen.
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MULTIFIBER SHIELDED CATHETER BEHAVIOR
VI.1 OVERVIEW
A multifiber optically shielded catheter of the type
described in Section V was constructed and used to produce
composite holes in atheroma to confirm that the design con-
cepts are valid, and to characterize the rate of tissue abla-
tion, and the size and shape of composite holes in a way
similar to that used in the single fiber experiments. A more
detailed study of the ablation yields, peripheral damage pro-
duced by tissue ablation, and thresholds for ablation are
presented in the next section.
VI.2 EXPERIMENTAL METHODS
The catheter used in the following experiments was an 8F
(2.5mm outer diameter) multifiber shielded catheter and laser
angiosurgery system described in Section V.
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The performance of the catheter was evaluated by firing
each of the 19 fibers in succession one or more times to pro-
duce composite holes in opened samples of fresh postmortem
fibrous atherosclerotic aorta immersed in saline or blood with
blue-green (all lines) argon ion laser light. At least three
composite holes were produced in a single tissue sample for
each combination of ablatiop parameters of laser power, expo-
sure time, and number of rounds. In all cases, the shield was
brought into contact with the intimal surface with a constant
force of 2 ounces (0.6N) to displace the fluid between the
shield and the sample. The optical shield was cleaned after
the production of each composite hole.
Composite hole diameters were measured using a dissecting
microscope with an eyepiece reticle. Composite hole depths
were measured using a histological microscope which could be
focused first at the tissue surface and then at the hole bot-
tom, and the travel of the microscope stage measured. Meas-
ured hole diameters and depths are accurate to +25um.
As in the single fiber study, an ablation velocity (v)
was computed from measured values of composite hole depth (1)
and exposure time (t) by the ratio: v = l/At. In addition,
for composite holes produced with multiple rounds, an
incremental advancement (i), or the incremental increase in
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composite hole depth with the number of rounds (n), was com-
puted as the ratio: i = Al/An.
VI.3 RESULTS
Three separate experiments were performed to characterize
the ablation process under varying ablation parameters and
conditions. In all cases,, mean composite hole depths were
computed and reported along with typical standard deviations
for each set of ablation parameters.
VI.3.1 Variation in Ablation Rate with Varying Power
The existence of a power dependence on the rate of tissue
ablation and composite hole formation in a single round was
examined by producing composite holes with single rounds from
the multifiber shielded catheter. Composite holes were made
with laser powers of 5.0W, 7.5W, and 10.OW using a number or
different exposure times.
With appropriately long exposure times, 2.5mm composite
holes with good crater overlap could be produced at 5.0W,
7.5W, and 10.OW. The structure of the composite hole depended
on the sequence in which the individual fibers were fired. If
the firing order was random, the resulting composite hole had
a very uneven bottom surface. If the sequence was outer ring
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first, then inner ring, then center fiber, the result was a
deep hole approximately 2mm in diameter surrounded by a shal-
low annular ring extending out to the 2.5mm shield diameter.
If the sequence was center fiber first, then inner ring, then
outer ring, the resulting hole had a smooth, uniform bottom
with a constant depth. Typical composite holes are shown in
Figure VI.1. All composite hole measurements reported were
made using the latter firing sequence.
The composite holes produced were relatively free of
char. Generally, cleaner composite holes with less char were
produced when using higher powers and shorter exposure times.
The resulting composite hole depths are plotted versus
exposure time in Figure VI.2, and thus represent a time his-
tory for composite hole formation. For all laser powers, the
composite hole increased linearly with exposure time, indicat-
ing a constant ablation velocity. In all cases, ablation
velocity increased with laser power. Ablation velocities for
all laser powers are listed in Table VI.1.
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Figure VI.1
Composite holes produced using the multi-
fiber catheter. A, 14W/50ms/lround in a
blood field; 1OW/10Oms/4rounds and
14W/72ms/4rounds (left and right) in a sa-
line field looking, B, down on the luminal
surface and, C, in cross section. Scale
divisions are in millimeters.
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500
exposure time (ms)
Figure VI.2
Composite hole depth versus exposure time
for single rounds with various
powers. A typical error bar is shown.
laser
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laser power ablation velocity
(W) (mm/sec)
5.0 2.5
7.5 3.8
10.0 6.4
Table VI.1
Ablation velocities for three laser powers
using the multifib'er catheter.
VI.3.2 Variation in Ablation Rate with Repeated Exposures
The second set of experiments was designed to evaluate
the advancement of the catheter when successive rounds are
fired, which is the intended mode of operation. Composite
holes were produced using 7.5W/25ms, 7.5W/50ms, 10W/12ms, and
10W/25ms exposures for varying numbers of rounds. The higher
powers and shorter exposure times were selected since the pre-
vious experiment showed that shallow composite holes with less
char were produced at these values.
The resulting composite hole depths are plotted versus
the number of exposures in Figure VI.3. For all combinations
of laser power and exposure time, the catheter was found to
advance into the sample under two ounces of force as tissue
was removed. Composite hole depth increased linearly with the
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number of rounds. Incremental advancement per round for each
combination of power
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and time is listed in Table VI.2.
0
number of rounds
Figure VI.3
Crater depth versus number of exposures
for photon doses of 10OW/35ms and 10OW/63ms
and a spot size of 500um. A typical error
bar is shown.
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laser power
and
exposure time
(W/ms)
7.5/25
7.5/50
10.0/12
10.0/25
incremental advancement
(um/round)
75
226
84
190
Table VI.2
Incremental advancement values for several
laser power and exposure time combinations
using the multifiber catheter.
VI.3.3 Selective Removal of Tissue with a Multifiber Catheter
As a final experiment, the ability of the multifiber
catheter to selectively remove portions of tissue in its field
of view was investigated by firing various groups of fibers in
the array in a single round. Examples of the removal patterns
obtained are shown in Figure VI.4.
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Figure VI.4
Selective removal of plaque using the mul-
tifiber catheter. Composite holes were
produced by firing selected fibers in the
19 fiber array. A, annulus; B, semicir-
cle. Scale divisions are in millimeters.
VI.4 DISCUSSION
As long as exposure times were longer than the practical
thresholds found in the single fiber experiments, complete
overlap of the individual craters formed relative clean compo-
site holes, indicating that the design concepts proposed for
multifiber shielded catheters are valid. The small variabil-
ity in composite hole depth shows that controlled, predictable
ablation is possible with the multifiber catheter, and that
safe restoration of a large lumen is possible.
Composite hole depth as a function of exposure time (Fig-
ure VI.2) again shows that in each case, depth increased
- 114 -
I
MULTIFIBER SHIELDED CATHETER BEHAVIOR
DISCUSSION
linearly with exposure time up to the point of perforation. A
constant ablation velocity was indicated, as it was in the
single fiber experiments. The velocities are higher by
approximately a factor of two than those measured for single
fiber exposure. This increase is primarily due to the overlap
of the laser light spot of each optical fiber with those of
its nearest neighbors (approximately 61% on average), produc-
ing an overall larger photon dose at a given tissue site. The
volume of tissue removed by a given laser power and spot size
were about the same in both single and multifiber devices.
The linear increase in composite hole depth as a function
of the number or rounds (Figure VI.3) indicates that the abla-
tion process is additive, as it was for single fiber expo-
sures, and that catheter advancement is constant with the
number of rounds.
The final experiments showed that the multifiber catheter
is capable of irradiating and removing only a fraction of the
tissue in its field of view, demonstrating the ability to
selectively remove only tissue deemed to be atheroma. This
ability can be combined with a diagnostic system to provide a
further safeguard against perforation, even at the bend in a
vessel, and to avoid irradiation of blood when treating a
vessel that is not totally occluded.
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VII.1 OVERVIEW
A multifiber optically shielded catheter of the type
described in Section V was used to produce composite holes in
atheroma to investigate how the efficiency of the ablation
process (through a defined "ablation yield") varies with abla-
tion parameters and conditions. Both power and exposure time
thresholds for ablation were identified. The extent and
character of peripheral damage was examined histologically
under varying conditions as well.
Results of these experiments give insight into the
laser/tissue interaction. The consequences of results are
discussed along with a comparison of the single fiber and mul-
tifiber ablation characteristics and comparison of the multi-
fiber ablation results to our ablation model.
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VII.2 EXPERIMENTAL METHODS
The catheter used in the following experiments was an 8F
(2.5mm outer diameter) multifiber shielded catheter and laser
angiosurgery system described in Section V.
The performance of the catheter was evaluated by firing
each of the 19 fibers in succession one or more times to pro-
duce composite holes in opened samples of fresh postmortem
fibrous atherosclerotic aorta immersed in saline or blood with
blue-green (all lines) argon ion laser light. Except where
indicated, three composite holes were produced for each com-
bination of ablation parameters of laser power (P), exposure
time (t), and number of rounds (n). The results of the previ-
ous section established that a firing sequence of center fiber
followed by successive fibers in the inner ring and outer
ring, in order, produced the most uniform composite holes.
That sequence was used for each round in this study as well.
Unless otherwise stated, the shield was brought into contact
with the intimal surface with a constant force of 2 ounces
(0.6N) to displace the fluid between the shield and the sam-
ple. Unless otherwise noted, the optical shield was cleaned
after the production of each composite hole.
Composite hole diameters (d) were measured using a dis-
secting microscope with an eyepiece reticle. Composite hole
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depths (1) were measured using a histological microscope which
could be focused first at the tissue surface and then at the
hole bottom, and the travel of the microscope stage measured.
Measured hole diameters and depths are accurate to +25um.
For each combination of ablation parameters, two compo-
site holes were randomly selected for histological evaluation.
Each was fixed in formalin, embedded in paraffin, serially
sectioned, and hematoxylin and eosin stained to determine the
degree of peripheral damage. The extent of damage was meas-
ured with an eyepiece reticle at 40x or 100x magnification to
+10um accuracy.
To compare tissue removal with different ablation parame-
ters, an ablation yield (Y), was computed by dividing the
volume of tissue removed by the total laser energy delivered:
Y = (d2/4)l/(19Ptn). From a knowledge of the ablation yield,
the tissue volume removed with a prescribed photon dose can be
calculated.
VII.3 RESULTS
Five separate experiments were performed to evaluate the
variation in ablation yield and extent of peripheral damage
with varying tissue samples, ablation parameters, and ablation
conditions. In all cases, mean composite hole diameters,
depths, and/or ablation yields were computed and reported
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along with standard deviations for each set of ablation
parameters.
VII.3.1 Variation in Ablation Yield in Different Tissue
Samples
The reproducibility of ablation yield was examined by
producing composite holes using a photon dose of
10W/50ms/3rounds (28.5J) in a number of different arterial
tissue samples. Table VII.1 lists the mean composite hole
diameters, depths, and ablation yields for each of seven sam-
ples ranging from relatively normal arterial wall to severely
complicated atherosclerotic lesions. Calcified plaque was not
included because argon ion laser light is not effective in
removing calcified lesions [1].
For all tissue samples, the composite hole diameter was
2.50+0.09mm. This equality of composite hole diameter and
catheter diameter was born out throughout all experiments,
which indicates that a composite hole diameter of 2.50mm can
be assumed and the ablation yield can be used to specify com-
posite hole depth by the relation:
1 = Y(19Ptn)/(ird2/4) = (3.87)YPtn for 1 in millimeters.
A total of 10 composite holes were produced in sample 1,
a fibrous plaque of the type used in all subsequent
experiments. The standard deviation of ablation yield in this
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hole
diameter
(mm)
2.51+0.11
hole
.depth
(um)
895+70
ablation
yield
(mm /J)
0.155+0.012
normal
normal
fibrous
complicated
complicated
fatty
2.48+0.10
2.45+0.18
2.50+0.09
2.48+0.07
2.55+0.18
2.53+0.19
926+50
1013+100
943+64
1000+72
841+67
1333+231
0.158+0.009
0.167+0.017
0.161+0.015
0.167+0.010
0.152+0.015
0.233+0.040
Table VII.1
Mean composite hole diameters, depths, and
ablation yields for seven tissue samples.
Variations are plus or minus one standard
deviation. All exposures were delivered
at a photon dose of 10W/50ms/3rounds.
sample was 8%, indicating the variation to be expected within
a single fibrous tissue sample. The standard deviation of
yield in all tissue types collectively was +16%, indicating
the variation to be expected across many tissue samples, even
if no knowledge of the tissue type is available. Note that
most of larger variation across tissue samples is due to an
increased ablation yield in fatty samples.
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VII.3.2 Variation in Ablation Yield and Damage with Varying
Power
The existence of a power dependence on ablation yield and
extent of damage was examined by producing composite holes us-
ing a constant energy of 47.5J delivered in 5 rounds. The
laser power was varied from 1W to 14.7W, and the exposure time
was varied from 500ms to 34ms to compensate for varying power.
The composite holes produced were relatively free of char
at all power levels, with some noticeable increase in char
production at lower powers (less than 3.5W). Histology showed
a 100-200um layer of vacuolation and hypereosinophilia sur-
rounding the hole (Figure VII.1). A region beyond that with
an average thickness of 950um showed collagen alteration typi-
fied by an increase in unstained space without hypereosino-
philia. The stained material was more fibrous in appearance,
aligning itself with the vessel surface. The structure of the
arterial wall did not appear to be compromised by this change.
Occasional splits in the media were observed up to several
millimeters from the hole.
The resulting ablation yields are plotted in Figure
VII.2. For powers of 3.5W and above, the ablation yield was
constant at 0.156mm3/J. The yield fell off rapidly for laser
powers less than 3.5W, falling to zero at 1W. Histology also
- 121 -
MULTIFIBER CATHETER ABLATION EFFICIENCY
RESULTS
Figure VII.la
Low magnification of a typical histologi-
cal section through a 2.5mm diameter com-
posite hole. Photon dose for this hole
was 8W/72ms/5rounds.
showed that there was little difference in the amount of peri-
pheral damage produced with laser powers over 3.5W. The
volume of tissue involved by vacuolation, as well as the de-
gree of hypereosinophilia and collagen alteration, remained
roughly constant throughout the experiments.
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Figure VII.lb
High magnification of a section of the
hole shown in Figure VII.la.
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15
laser power (W)
Figure VII.2
Ablation yield versus laser power. All
photon doses were delivered at an energy
of 47.5J. Number of rounds was constant
at 5.
Variation in Ablation Yield and Damage with Varying
Exposure Time
The existence of an energy dependence on ablation yield
and extent of damage was examined by producing composite holes
using a constant energy of 28.5J delivered at 10W. The
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exposure time was adjusted from 9ms to 150ms to vary the
energy per round (or likewise, per crater), and the number of
rounds ranged from 1 to 17 to compensate for varying exposure
time.
The resulting ablation yields are plotted in Figure
VII.3. For exposure times of 17ms and above, ablation yield
was constant at 0.157mm 3/J. The yield fell off rapidly for
exposure time less than 17ms, falling to zero at 10ms. No
significant variation in damage could be detected on histolog-
ical analysis of composite holes produced with exposure times
over 17ms.
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Figure VII.3
Ablation yield versus exposure time. All
photon doses were delivered at an energy
of 28.5J. Laser power was constant at
10W.
VII.3.4 Variation in Ablation Yield with Varying Advancing
Force
To investigate the effect of varying the force used to
advance the catheter into the forming
composite
composite hole,
holes were produced using a photon dose of
10W/50ms/3rounds (47.5J). The advancing force was varied from
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0.14N (equivalent to 0.5 ounces) to 0.83N (equivalent to 3.0
ounces).
The resulting ablation yields are plotted in Figure
VII.4. The ablation yield increased linearly with increasing
advancing force from a
0.205mm3/J at 0.83N.
value of 0.101mm3/J at 0.14N to
force (ounces)
Figure VII.4
Ablation yield versus advancing
All exposures were delivered at a
dose of 10W/50ms/5rounds.
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VII.3.5 Variation in Ablation Yield and Damage with Varying
Delay Times
The effect of varying inter-fiber delay times on the ab-
lation process was investigated by pausing between the firing
of each fiber to allow the tissue to cool. Composite holes
were produced using using a photon dose of 10W/50ms/3rounds
(47.5J), with inter-fiber delays from 170ms to 4.2s.
The resulting ablation yields are plotted in Figure
VII.5, and the thickness of the layers of vacuolation and col-
lagen alteration are plotted in Figure VII.6. The ablation
yield was constant at 0.154mm3/J for all delay times, and the
thickness of the vacuolation layer remained constant at 150um
for all delay times. The thickness of the layer of collagen
alteration remained constant at 1045um for delay times less
than 1.4s, but decreased gradually for delay times of 1.4s and
above.
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0
inter-fiber delay time (ms)
Figure VII.5
Ablation yield versus delay time. All ex-
posures were delivered at a photon dose of
10W/50ms/5rounds.
4500
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Figure VII.6
Thickness of vacuolation and collagen al-
teration layers versus delay time.
exposures were
1OW/50ms/5rounds.
All
at a photon dose of
VII.3.6 Variation in Ablation Yield with Catheter Usage
The consistency of ablation yield and the effect of
repeated catheter use was examined by repeatedly delivering
photon doses of 10OW/30ms/2rounds (11.4J) to produce many
composite holes. A single, newly constructed catheter was
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used for the entire study, with no cleaning of the shield
between firings.
The resulting ablation yields are plotted in Figure
VII.7. Ablation yield was constant at 0.160mm3 /J over the en-
tire experiment, essentially equal to the average yield of the
previous experiments. After the experiment was completed, the
output surface of the shield appear frosted or ptted, with
small points of char embedded slightly below the shield's sur-
face.
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Figure VII.7
Ablation yield versus number of exposures.
All exposures were delivered at a photon
dose of 1OW/30ms/2rounds.
VII.4 DISCUSSION
15
The small variability in composite hole depth and abla-
tion yield over different tissue types illustrates the con-
sistency of laser ablation using a precisely controlled photon
dose. This precise dosimetry could not be possible without
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the controlled light delivery provided by the optical shield
concept. This consistency also reinforces the validity of
subsequent results, and their applicability to a variety of
arterial lesions. Even if the exact composition of the target
lesion is not known, the volume of tissue removed by a
specific amount of delivered energy can be accurately pre-
dicted.
The results of the experiment which varied laser power
(Figure VII.2) illustrate the existence of a power threshold
for tissue ablation. For powers less than 1W, energy was not
delivered to the tissue as fast as thermal diffusion took it
away. The tissue may have been heated, but the energy re-
quired for phase change could not accumulate and no ablation
took place. For powers greater than 1W, the rate of energy
deposition was greater than thermal diffusion, energy was al-
lowed to accumulate, and ablation began. The ablation yield
increased from zero to a constant value at 3.5W as a decreas-
ing fraction of the laser power was thermally conducted away.
For laser powers greater than 3.5W, the ablation yield was
constant at 0.16mm 3/J, indicating that the fraction of energy
lost to thermal conduction was small enough to be insignifi-
cant. At this point, only the energy delivered, and not the
rate of delivery, is important.
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The results of the experiment which varied exposure time
(Figure VII.3) illustrate the existence of an -energy threshold
for the ablation process as well. All exposures in this ex-
periment were made at 10W, well above the power threshold for
ablation. However, for exposure times less than 10ms, enough
energy could not be deposited to raise the tissue to its abla-
tion temperature and accumulate the energy necessary to begin
phase change. This energy necessary for ablation to begin
could be thought of as a startup energy, and is equal to
approximately (10W)x(lOms) = 0.10J per fiber. Note that since
all photon dos s were delivered with more than one round, the
startup energy must have been deposited each time the tissue
was irradiated, and did not accumulate over multiple expo-
sures. For exposure times greater than 10ms, more than the
startup energy was deposited, and ablation began. The abla-
tion yield increased from zero to a constant value at 17ms
(0.17J) as the startup energy became a decreasing fraction of
the total energy delivered. For exposure times greater than
17ms, the ablation yield was again constant at 0.16mm3/J, in-
dicating that the fraction of energy lost to the startup pro-
cess was small enough to be insignificant. At this point,
only the energy delivered, and not the startup energy
delivery, is important.
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It is important to note that the threshold time for abla-
tion using the multifiber catheter, 10ms to 17ms, is of the
same order as the thresholds for ablation using the single
fiber shielded device with spot diameter of 750um, 17ms for an
absolute threshold and 25ms for a practical threshold,
described in Section III. It is not clear how adjacent, over-
lapping fibers in the multifiber catheter may effect each
other, but dehydration of the tissue exposed by adjacent
fibers may contribute to the slight lowering of this thres-
hold. Note that the absolute threshold predicted by the model
described in Section IV, to = (h0 +Hvap)D/f(d)I, is of the
order of lOOms, using the properties of water and D = 1/3mm.
As suggested in that section, it is likely that high power
laser irradiation of tissue and the onset of ablation greatly
alter the penetration depth making D << 1/3mm. This may well
account for the inaccuracy of this prediction.
The change in ablation yield with varying advancing force
(see Figure VII.4) illustrates the effect of user variation in
the pressure exerted when recanalizing a vessel. Increasing
the advancing force produced a predictable increase in the ab-
lation yield, which rose linearly from 0.101mm3/J at 0.5
ounces force to 0.205mm 3 /J at 3.0 ounces force. It is
unlikely that this increase is due to compression of the
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tissue, and not actually an increase in the volume of tissue
ablated, since histological examination did not show signs of
permanent tissue compression. It may be possible that the
optical properties of the tissue change as the tissue is
reversibly compressed, although a significant change in the
optical properties would not be expected. It is more likely
that the shield forces interstitial water from the tissue, and
thus reduces the amount of energy that is needed to ablate a
volume of tissue by reducing its effective heat of ablation.
Although the variation is non-zero, it is relatively small
with a factor of two increase in ablation yield for a factor
of six increase in advancing force. Note that the variability
in ablation yield did not change with force.
The lack of change in the ablation yield with increasing
delay time (Figure VII.4) indicates that, if exposures from
neighboring optical fibers in the fiber array have any effect
on the ablation yield, either increasing or decreasing it, the
effect is not time dependent on a time scale of 170ms to 4.2s.
The characteristic time for thermal relaxation (t) can be
estimated using the thermal diffusivity of water (k) and tak-
ing the characteristic length of the thermal gradient to be
the penetration depth of laser light (D) in the relation
t = D2/k. For blue-green argon ion laser light on fibrous
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plaque, the penetration depth is approximately 1/3mm [2,3].
This gives a thermal relaxation time of
= (1/3mm)2 /(0.1mm2 /s) = l.1s. Since delay times bracketed
this relaxation time well, it is not likely that exposures
from neighboring optical fibers effect the ablation yield in
any way in which the accumulation of heat which can be con-
ducted away by thermal diffusion (such as temperature eleva-
tion) plays a role.
Likewise, the thickness of the layer of vacuolation was
constant at approximately 150um for all delay times (Figure
VII.5), indicating that vacuolation formation may not be
governed by thermal processes effected by thermal diffusion.
Instead, vacuolation may be a direct consequence of ablation
itself.
However, the change in the thickness of the layer of col-
lagen alteration with varying delay time (Figure VII.5) indi-
cates that thermal diffusion may play a role in this type of
peripheral damage. For delay times less than s, not enough
time elapsed between the exposures of neighboring fibers to
allow the tissue to cool through thermal diffusion. The
thickness of the layer of collagen alteration was approx-
imately constant at 1050um. For delay times greater than s,
the tissue cooled between exposures and the thickness of this
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layer decreased to nearly zero at 4.2s. The elimination of
collagen alteration for long delay times indicates that this
layer corresponds to a thermally heated zone that may be re-
duced or eliminated by delays longer than the thermal relaxa-
tion time.
Note that this total amount of peripheral damage, even at
the shortest delay times, is,much less than has been reported
earlier by other investigators [4,5]. This is probably due to
the careful control of photon dose, using higher laser inten-
sities for very short exposure times.
The lack of change in ablation yield after multiple expo-
sures without cleaning (Figure VII.6) illustrates that the ab-
lation efficiency of a single device is not effected
significantly by use, or by char or debris on the shield sur-
face. Extended use of a single device produces some pitting
of the outer surface of the shield. However, even when severe
pitting had been caused by several hundred exposures, device
efficiency was not effected. Extended use of a single device
is possible without the need to clean the shield.
As described in Section IV, the efficiency of the abla-
tion process () is expected to be equal to:
= f(d) (1 - I ) (1 - t)
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For high intensities (high powers at a fixed spot diameter),
and at long exposure times, the efficiency should be approx-
imately constant:
= f(d) d 85039d + 4D = 850 + (4)(1/3)
The expected ablation yield, for water would be 1/(2.50J/mm3),
or 0.40mm3/J. The ablation yield for water multiplied by the
expected efficiency, (0.39)(0.40) = 0.16mm 3/J, agrees remark-
ably well with the values measured in this set of experiments.
An ablation yield can be computed for the single fiber
device with a spot diameter of 750um, described in Section
III. In this case, Y = Av/P = 0.11mm3 /J. Note that this
yield is lower than that measured for the multifiber catheter.
Again, it is unclear what effect exposures for adjacent, over-
lapping fibers may have, but the effect appears to be to both
lower the threshold time and increase the ablation yield, or
the efficiency of the ablation process. Alteration of the
tissue properties such as dehydration or char formation to
decrease D is the probable explanation for this increased
yield, although it is also possible that some of the energy
deposited in the Ta p region surrounding the bottom of ayap
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crater is "recovered" by the adjacent fibers through tissue
dehydration or preheating.
It should be noted that, because all of the experiments
used a catheter with a constant light spot diameter of
800-900um, they could only show the effects of power and
energy thresholds. The important parameters are more likely
to be intensity (power per unit area) and fluence (energy per
unit area). In these terms, the intensity threshold would be
2 2(1W)/ (0.085cm/2)2/4 = 180W/cm2 , and the fluence threshold
would be (0.10J)/ (0.085/2)2/4 = 18J/cm2. The characteristic
time for thermal relaxation, however, is not dependent upon
the catheter, but the tissue properties and laser wavelength.
Therefore, delay time results may be applicable to other
catheter configurations using the argon ion laser.
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LASER ANGIOSURGERY IN AN ANIMAL MODEL
VIII.1 OVERVIEW
The behavior of the multifiber laser angiosurgery system
has been well characterized in vitro using human artery sam-
ples obtained at autopsy. As a collaborative effort in con-
juction with the Cleveland Clinic Foundation, experiments are
currently underway to characterize the behavior of the multi-
fiber laser catheter and the ablation system in an animal
model in -vivo. Although those studies are far from comple-
tion, it is illustrative to briefly describe the results of
one such experiment here to demonstrate the success of the
system.
The following section describes a typical animal experi-
ment in which a surgically induced obstructive lesion in a
dog's carotid artery was ablated using the multifiber laser
catheter and ablation system described in Section V. The
animal was followed for up to two months angiographically
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without complication. This experiment demonstrates that the
controlled light delivery concepts of the optical shield, the
design and careful characterization of the multifiber
catheter, and the integrated ablation system can be used to
successfully treat obstructive lesions in vivo.
VIII.2 THE ANIMAL MODEL
A number of animal models have been described for use as
a testing ground for laser ablation of atheroma [1-5], includ-
ing the combined use of a hypercholesterolemic diet and deen-
dothelialization in rabbits and swine, arterial ligation
models in dogs, and human xenografts in the arterial circula-
tion of dogs. Unfortunately, it may always remain difficult
to find a good model, since humans are nearly unique in their
development of this atherosclerosis. Spontaneous regression
of the lesions that are produced, and the unknown rate of re-
formation of lesions after laser treatment may always cloud
results. However, success of the ablation system, and healing
of the laser treated site (i.e., reendothelialization,
thrombus formation, etc.) can be investigated.
In a study ongoing at the Cleveland Clinic Foundation,
fibrous arterial lesions have been induced in the common
carotid artery of a dog by exposing the artery surgically and
- 143 -
LASER ANGIOSURGERY IN AN ANIMAL MODEL
THE ANIMAL MODEL
placing crossed cat-gut sutures through the intima and media,
into the vessels lumen, to form an "X" shape (see Figure
VIII.1). In most cases, a total of two or four pairs of
crossed sutures are placed in several locations along the
artery. The wound is closed and allowed to heal. Over the
next six weeks, the animal generally develops a prolifera-
tive/fibrous reaction to the induced injury somewhat similar
to early atherosclerotic plaques.
In the case of the animal presented in this example, the
severity of the lesion produced by this procedure was
evaluated by angiography at six weeks to be approximately 80%
(less than 1mm diameter lumen in a vessel with a previous
diameter of about 4mm), and is shown in Figure VIII.2. Note
that a second, less severe lesion appears approximately cm
distal to the 80% stenosis where a second set of crossed su-
tures were placed in the vessel.
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m
Figure VIII.1
Diagram of the induction of fibrous le-
sions in the dog model used in these ex-
periments, and of the intraoperative
approach that was used to treat it.
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Figure VIII.2
Angiogram showing the extent of obstruc-
tion in the right carotid of a dog. Note
two lesions, a proximal obstruction of
approximately 80%, and a more distal ob-
struction of much less severity. A metal
marker indicates the lesion to be removed.
The apparent "obstruction" several cen-
timeters distal to the lesions is due to a
surgical tie and will appear in certain
subsequent angiograms as well.
VIII.3 EXPERIMENTAL PROCEDURE
The lesions were approached surgically by incision and
blunt dissection to isolate the artery to be treated. An
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arteriotomy was made approximately 5cm proximal to the first
lesion, through which an 8F (2.5mm) multifiber shielded
catheter was introduced. The catheter was advanced antegrade
until it contacted the first lesion and met with resistance to
forward pressure. The lesion could not be crossed mechani-
cally with added advancing force.
The lesion was ablated, using 7W/50ms/2round exposures (a
total of 13.3J), which were repeated until the catheter could
be advanced past the site of the lesion. The second lesion
was not severe enough to impair catheter advancement and was
not treated. After treatment, the arteriotomy was closed and
the progress of the dog followed by angiography until sacrif-
ice.
VIII.4 RESULTS
A total of five exposures (66.5J) were required to re-
lieve the lesion and create a new lumen 2.5mm in diameter
through which the catheter could easily pass. The
post-procedure angiogram is shown is Figure VIII.3, clearly
demonstrating that the degree of obstruction has been reduced
from the 80% lesion shown in Figure VIII.2 to approximately
35% (a 2.5mm diameter lumen in a 4mm diameter vessel).
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Figure VIII.3
Angiogram of the right carotid of the same
dog immediately after laser treatment.
The treated site is marked with a metal
pointer. The apparent "high grade ob-
struction" distal to the treated site is
due to a vascular tie.
Angiography at two days, one week, and three weeks was
essentially indistinguishable from the postprocedure angiogra-
phy shown in Figure VIII.3. Figure VIII.4 shows an angiogram
two weeks after treatment.
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Figure VIII.3
Angiogram of the right carotid of the same
dog two weeks after laser treatment.
VIII.5 DISCUSSION
This example clearly demonstrated the success of the mul-
tifiber catheter and angiosurgery system in vivo. The pro-
cedure was not complicated by acute perforation or thrombus
formation. The vessel remained patent with normal healing of
the intimal surface and reendothelialization.
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Characterization of the multifiber catheter in vitro in
cadaver artery samples indicated that ablation proceeded with
a constant ablation yield of 0.16mm3/J, independent of the
type of tissue ablated. Based on this result, the 66.5J
delivered to treat the lesion in this animal should have
removed 10.6mm3 of tissue, or a cylinder 2.5mm in diameter and
approximately 2mm long. This agrees well with the estimated
length of the treated lesion, indicating that the system per-
forms in vivo as it did in vitro.
Animal studies are continuing at the Cleveland Clinic
Foundation in an attempt to gain more information on the
behavior of the catheter and ablation system, the host
response to laser ablation, and advancements in catheter
design necessary to proceed to percutaneous use.
Preliminary results of treatment of surgically induced
focal fibrous plaques in the carotid arteries of 22 similarly
prepared dogs using 8F (2.5mm diameter) shielded multifiber
catheters and the 4.5F (1.5mm diameter) shielded multifiber
catheters also developed in our laboratory [6] have recently
been reported [7]. Laser treatment was carried out in an open
surgical field via an arteriotomy proximal to the lesion in 11
dogs and via femoral artery cannulation in the other 11 using
fluoroscopic guidance. Lesion removal, vessel patency, and
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healing was examined by angiography, histology, and electron
microscopy up to eight weeks post-treatment. The results
showed that the lesion could be removed without peripheral
arterial damage under the controlled delivery conditions af-
forded by the multifiber laser angiosurgery system. No per-
forations or aneurysms occurred. Thrombosis, when present,
was seen only in dogs treated intra-operatively and was asso-
ciated with the arteriotomy site proximal to the laser treated
site. Reendothelialization was complete within three weeks
and vessels remained patent up to eight weeks.
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CONCLUSION
IX.1 CONCLUSIONS FROM THIS STUDY
Many researchers have demonstrated the ability to remove
arterial tissue using laser energy. However, successful laser
treatment of atheromatous plaque has been limited by complica-
tions including acute perforation, aneurysm formation, and
thrombosis of the treated site. Many of these complications
are likely to be due to incomplete control of the delivery of
laser energy.
A single fiber shielded delivery scheme was shown to al-
low control of the tissue ablation process, through the con-
trol of laser light delivery. This scheme also has several
practical features. The shield isolates and protects the
fragile output tip of the optical fiber, the site of highest
laser intensity, from the corrosive environment of the intra-
vascular contents and ablation products. Char and debris
cannot accumulate on the fiber tip, greatly decreasing the
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probability of fiber failure. If failure should occur the
shield protects the patient. Debris deposited on the output
surface of the shield does not endanger the fiber itself.
The ablation process was shown to be quantifiable.
Removal of arterial tissue and atheromatous plaque was both
consistent and predictable. Under these conditions, an under-
standing of the ablation process is possible.
Requirements for the successful recanalization of an ob-
structed vessel were discussed and a multifiber shielded
catheter and support system was developed to meet those re-
quirements. The system was shown to be capable of removing
large amounts of tissue in a controlled way, making it capable
of safely producing a large diameter lumen in an obstructed
vessel. Although the laser angiosurgery system developed was
relatively complex, operation of the system was made simple
through a- high degree of computer control and safe through a
control system that monitored the system's status, and the
behavior of the system was very simple to understand. Abla-
tion progressed at a constant rate which could be predicted
based on the power and exposure time selected.
The results of this study provide information about the
range of appropriate photon doses over which tissue can be
removed using the multifiber shielded catheter described, and
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the histological effects of those doses. They also provide
insight into the thermal ablation process using this catheter
and the argon ion laser that may be valid for other continuous
lasers as well.
The constancy of the ablation yield over a wide range of
exposure combinations above threshold indicates that if laser
light is introduced in a coqntrolled way, and within the expo-
sure ranges investigated, the ablation yield can be assumed to
a constant equal to 0.16mm3/J, even if the makeup of the
target lesion is not completely known. The volume of tissue
removed is dependent upon the total energy delivered, and not
upon the laser power or exposure time. Only the rate of tis-
sue removal is effected by these parameters. Since the compo-
site hole was consistently fixed at a diameter of 2.5mm, the
depth of a hole produced by a given amount of delivered energy
(E) can be computed simply by the relation
1 = YE/(tid 2/4) = (32um/J)E.
The existence of a power threshold of 1W indicates a
minimum rate of energy delivery required to overcome the
losses of energy due to thermal diffusion. Ablation may only
take place at powers greater than 1W, with a constant ablation
yield of 0.16mm3 /J for powers greater than 3.5W. The
existence of an energy threshold of 0.10J indicates a minimum
energy that must be deposited each time a fiber is fired be-
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fore ablation can occur. Likewise, a constant ablation yield
3
of 0.16mm /J was reached for energies greater than 0.17J.
An unavoidable layer of vacuolation and hypereosinophilia
approximately 150um thick is produced around each composite
hole. However, a layer of collagen alteration beyond that can
be reduced by increasing the amount of time between successive
fiber firings. This second type of damage appears to be re-
lated to thermal heating of the surrounding tissue, decreasing
if delay times greater than the characteristic time for
thermal relaxation of 1.ls are used. The collagen alteration
seen in the second layer did not compromise the structure of
the vessel wall, and would probably be repaired by the host
without effect.
A simple theoretical model of the thermal ablation pro-
cess was presented as a tool to understand the ablation pro-
cess and the important parameters that govern it. Through
some simple approximations, equations which predict the abla-
tion velocity and ablation efficiency were developed. These
equations illustrate how changes in certain ablation condi-
tions can effect the ablation process. For example, going to
larger diameter laser spots increases the ablation velocity
and efficiency. Using a laser wavelength more strongly
absorbed by the tissue has the same effect. The model was
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shown to predict the ablation velocity and ablation efficiency
of both single fiber and multifiber devices with some ac-
curacy. However, it was obvious from the inaccuracy of thres-
hold time and damage layer predictions that the model must be
developed further. In particular, a better understanding of
the penetration depth and how it changes during high power ir-
radiation and ablation, the form of the f(d) efficiency fac-
tor, and interaction of adjacent fibers in the multifiber
device are necessary. Those efforts are in progress, being
undertaken by other members of the Laser Angiosurgery Group.
Successful recanalization of an animal model was
demonstrated using the multifiber shield catheter and ablation
system. A full in vivo characterization of the laser an-
giosurgery system is underway at the Cleveland Clinic Founda-
tion in conjunction with this lab. Preliminary findings show
that the shielded catheter concept allows for the controlled
ablation of obstructions in vivo with a minimization of the
complications experienced by other investigators. They also
illustrate that the integrated multifiber catheter ablation
system is reliable and well suited to an in vivo environment.
The Federal Drug Administration has given approval for
the testing of both the 8F (2.5mm) and 4.5F (1.5mm) multifiber
catheters, along with the ablation system as described here,
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in the coronary arteries of human subjects during internal
mammary artery bypass surgery. Although this procedure will
not test the usefulness of the system in a percutaneous mode,
it will give extremely important information regarding the hu-
man host's response to the ablation of atherosclerotic plaques
under the controlled conditions afforded by the multifiber
laser angiosurgery system. An operating room has been con-
structed at the Cleveland Clinic Foundation specifically
designed to accomodate the angiosurgery system. The complete
optical and control systems described in this work have been
duplicated there for animal and human trials. Human trials
should be beginning soon.
One of the advantages of the multifiber design is that
selective removal of tissue is possible. Spectral diagnosis
of the tissue in each fiber's field of view using the
fluorescence generated by exposure to low level laser light
may allow the determination of which fibers should be fired
prior to ablation. Incorporation of spectral diagnostics is
currently being investigated as a parallel effort by members
of the MIT Laser Angiosurgery Group.
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